| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | CACNA1E SCN11A ABCA2 ATP8B4 SLC2A9 SLC37A3 TRPC4 TRPC5 SLC22A15 XKR8 ATP9B ANO10 PKD1L2 ATP9A SLC30A4 SLC2A3 CHRNB1 SLC2A4 SLC5A11 SLC6A2 SLC6A4 ORAI1 SIDT2 SLC9A1 SLC46A3 SLC9A3 PIEZO2 KCNA5 ANO6 TSPO2 GLRB KCNK10 SCN10A SLC4A10 SLC9A7 SV2C ATP11C KCNK17 TMEM109 SLC33A1 | 1.12e-16 | 1289 | 135 | 40 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1E SCN11A ABCA2 SLC2A9 SLC37A3 TRPC4 TRPC5 SLC22A15 ANO10 PKD1L2 SLC30A4 SLC2A3 CHRNB1 SLC2A4 SLC5A11 SLC6A2 SLC6A4 ORAI1 SIDT2 SLC9A1 SLC46A3 SLC9A3 PIEZO2 KCNA5 ANO6 TSPO2 GLRB KCNK10 SCN10A SLC4A10 SLC9A7 SV2C KCNK17 TMEM109 SLC33A1 | 5.57e-14 | 1180 | 135 | 35 | GO:0022857 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1E SCN11A SLC2A9 TRPC4 TRPC5 ANO10 PKD1L2 SLC30A4 CHRNB1 SLC2A4 SLC5A11 SLC6A2 SLC6A4 ORAI1 SLC9A1 SLC46A3 SLC9A3 PIEZO2 KCNA5 ANO6 KCNK10 SCN10A SLC4A10 SLC9A7 KCNK17 TMEM109 | 3.49e-13 | 664 | 135 | 26 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1E SCN11A SLC2A9 TRPC4 TRPC5 ANO10 PKD1L2 SLC30A4 CHRNB1 SLC2A4 SLC5A11 SLC6A2 SLC6A4 ORAI1 SLC9A1 SLC46A3 SLC9A3 PIEZO2 KCNA5 ANO6 GLRB KCNK10 SCN10A SLC4A10 SLC9A7 KCNK17 TMEM109 | 3.06e-12 | 793 | 135 | 27 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1E SCN11A SLC2A9 SLC37A3 TRPC4 TRPC5 ANO10 PKD1L2 SLC30A4 SLC2A4 SLC5A11 SLC6A2 SLC6A4 ORAI1 SLC9A1 SLC46A3 SLC9A3 KCNA5 ANO6 GLRB KCNK10 SCN10A SLC4A10 SLC9A7 KCNK17 | 4.33e-11 | 758 | 135 | 25 | GO:0015318 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1E SCN11A TRPC4 TRPC5 PKD1L2 SLC30A4 SLC5A11 SLC6A2 SLC6A4 ORAI1 SLC9A1 SLC46A3 SLC9A3 KCNA5 KCNK10 SCN10A SLC4A10 SLC9A7 KCNK17 | 3.55e-10 | 465 | 135 | 19 | GO:0046873 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1E SCN11A SLC2A9 TRPC4 TRPC5 PKD1L2 SLC30A4 SLC2A4 SLC5A11 SLC6A2 SLC6A4 ORAI1 SLC9A1 SLC46A3 SLC9A3 KCNA5 KCNK10 SCN10A SLC4A10 SLC9A7 KCNK17 | 1.43e-09 | 627 | 135 | 21 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1E SCN11A TRPC4 TRPC5 ANO10 PKD1L2 CHRNB1 SLC6A4 ORAI1 PIEZO2 KCNA5 ANO6 KCNK10 SCN10A KCNK17 TMEM109 | 1.47e-09 | 343 | 135 | 16 | GO:0005261 |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 1.77e-09 | 51 | 135 | 8 | GO:0140303 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1E SCN11A TRPC4 TRPC5 ANO10 PKD1L2 CHRNB1 SLC6A4 ORAI1 PIEZO2 KCNA5 ANO6 GLRB KCNK10 SCN10A KCNK17 TMEM109 | 1.39e-08 | 459 | 135 | 17 | GO:0005216 |
| GeneOntologyMolecularFunction | channel activity | CACNA1E SCN11A TRPC4 TRPC5 ANO10 PKD1L2 CHRNB1 SLC6A4 ORAI1 PIEZO2 KCNA5 ANO6 GLRB KCNK10 SCN10A KCNK17 TMEM109 | 9.77e-08 | 525 | 135 | 17 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1E SCN11A TRPC4 TRPC5 ANO10 PKD1L2 CHRNB1 SLC6A4 ORAI1 PIEZO2 KCNA5 ANO6 GLRB KCNK10 SCN10A KCNK17 TMEM109 | 1.00e-07 | 526 | 135 | 17 | GO:0022803 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC2A9 SLC37A3 SLC30A4 SLC2A4 SLC5A11 SLC6A2 SLC6A4 SLC9A1 SLC46A3 SLC9A3 SLC4A10 SLC9A7 | 8.23e-07 | 296 | 135 | 12 | GO:0015291 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR2A14 DDR1 DRD1 GPR19 OR2L3 NPSR1 MC1R P2RY13 VN1R1 GPR139 CHRNB1 EDNRA OR2L2 TAS2R14 ADRB3 TAS2R5 OR10A4 GLRB OR10AD1 CCR4 ROS1 CCR5 CCR6 IL6ST HCRTR2 EPHA1 | 1.12e-06 | 1353 | 135 | 26 | GO:0004888 |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 1.14e-06 | 28 | 135 | 5 | GO:0140326 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR2A14 DRD1 GPR19 OR2L3 NPSR1 MC1R P2RY13 VN1R1 GPR139 EDNRA OR2L2 TAS2R14 ADRB3 TAS2R5 OR10A4 OR10AD1 CCR4 CCR5 CCR6 HCRTR2 | 2.06e-06 | 884 | 135 | 20 | GO:0004930 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SCN11A SLC5A11 SLC6A2 SLC6A4 SLC9A1 SLC9A3 SCN10A SLC4A10 SLC9A7 | 2.49e-06 | 171 | 135 | 9 | GO:0015081 |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1E ANO10 CHRNB1 PIEZO2 KCNA5 ANO6 GLRB KCNK10 SCN10A KCNK17 TMEM109 | 1.72e-05 | 334 | 135 | 11 | GO:0022836 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCA2 SLC2A9 SLC37A3 SLC30A4 SLC2A4 SLC5A11 SLC6A2 SLC6A4 SLC9A1 SLC46A3 SLC9A3 SLC4A10 SLC9A7 | 2.17e-05 | 477 | 135 | 13 | GO:0022804 |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 2.26e-05 | 25 | 135 | 4 | GO:0015149 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 2.26e-05 | 25 | 135 | 4 | GO:0055056 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 3.11e-05 | 27 | 135 | 4 | GO:0015145 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 4.16e-05 | 29 | 135 | 4 | GO:0051119 | |
| GeneOntologyMolecularFunction | antiporter activity | 4.29e-05 | 138 | 135 | 7 | GO:0015297 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 5.71e-05 | 196 | 135 | 8 | GO:0005319 | |
| GeneOntologyMolecularFunction | store-operated calcium channel activity | 6.36e-05 | 12 | 135 | 3 | GO:0015279 | |
| GeneOntologyMolecularFunction | symporter activity | 7.28e-05 | 150 | 135 | 7 | GO:0015293 | |
| GeneOntologyMolecularFunction | potassium:proton antiporter activity | 1.04e-04 | 14 | 135 | 3 | GO:0015386 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 1.59e-04 | 119 | 135 | 6 | GO:0015294 | |
| GeneOntologyMolecularFunction | sodium:proton antiporter activity | 1.59e-04 | 16 | 135 | 3 | GO:0015385 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.65e-04 | 171 | 135 | 7 | GO:0015103 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 1.83e-04 | 42 | 135 | 4 | GO:0015144 | |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 1.92e-04 | 17 | 135 | 3 | GO:0005402 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 2.01e-04 | 43 | 135 | 4 | GO:0140828 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 2.07e-04 | 125 | 135 | 6 | GO:0015108 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC2A9 SLC2A4 SLC5A11 SLC6A2 SLC6A4 SLC9A1 SLC9A3 SLC4A10 SLC9A7 | 2.12e-04 | 301 | 135 | 9 | GO:0022853 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 2.42e-04 | 182 | 135 | 7 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 2.58e-04 | 184 | 135 | 7 | GO:0022832 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 2.71e-04 | 19 | 135 | 3 | GO:0022821 | |
| GeneOntologyMolecularFunction | C-C chemokine receptor activity | 4.85e-04 | 23 | 135 | 3 | GO:0016493 | |
| GeneOntologyMolecularFunction | phospholipid scramblase activity | 4.85e-04 | 23 | 135 | 3 | GO:0017128 | |
| GeneOntologyMolecularFunction | C-C chemokine binding | 5.51e-04 | 24 | 135 | 3 | GO:0019957 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 5.71e-04 | 151 | 135 | 6 | GO:0008509 | |
| GeneOntologyMolecularFunction | G protein-coupled chemoattractant receptor activity | 7.01e-04 | 26 | 135 | 3 | GO:0001637 | |
| GeneOntologyMolecularFunction | chemokine receptor activity | 7.01e-04 | 26 | 135 | 3 | GO:0004950 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 7.85e-04 | 27 | 135 | 3 | GO:0051139 | |
| GeneOntologyMolecularFunction | outward rectifier potassium channel activity | 7.85e-04 | 27 | 135 | 3 | GO:0015271 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 9.66e-04 | 167 | 135 | 6 | GO:0015079 | |
| GeneOntologyMolecularFunction | carbohydrate:proton symporter activity | 1.24e-03 | 8 | 135 | 2 | GO:0005351 | |
| GeneOntologyMolecularFunction | chemokine binding | 1.42e-03 | 33 | 135 | 3 | GO:0019956 | |
| GeneOntologyMolecularFunction | fructose transmembrane transporter activity | 1.58e-03 | 9 | 135 | 2 | GO:0005353 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 1.59e-03 | 74 | 135 | 4 | GO:0005548 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.85e-03 | 129 | 135 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | angiotensin receptor binding | 1.97e-03 | 10 | 135 | 2 | GO:0031701 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 2.11e-03 | 133 | 135 | 5 | GO:0008528 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 2.22e-03 | 81 | 135 | 4 | GO:0015370 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 2.64e-03 | 140 | 135 | 5 | GO:0001653 | |
| GeneOntologyMolecularFunction | monoamine transmembrane transporter activity | 2.86e-03 | 12 | 135 | 2 | GO:0008504 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 3.07e-03 | 145 | 135 | 5 | GO:0004713 | |
| GeneOntologyMolecularFunction | catecholamine binding | 3.37e-03 | 13 | 135 | 2 | GO:1901338 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 3.65e-03 | 151 | 135 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 3.75e-03 | 152 | 135 | 5 | GO:0022843 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 3.91e-03 | 14 | 135 | 2 | GO:0070679 | |
| GeneOntologyMolecularFunction | cytokine receptor activity | 4.26e-03 | 97 | 135 | 4 | GO:0004896 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 4.70e-03 | 50 | 135 | 3 | GO:0099095 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 4.97e-03 | 51 | 135 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | potassium ion leak channel activity | 5.12e-03 | 16 | 135 | 2 | GO:0022841 | |
| GeneOntologyMolecularFunction | floppase activity | 5.12e-03 | 16 | 135 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | SH2 domain binding | 5.24e-03 | 52 | 135 | 3 | GO:0042169 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 5.53e-03 | 53 | 135 | 3 | GO:0008188 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 5.77e-03 | 17 | 135 | 2 | GO:0015378 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 6.47e-03 | 18 | 135 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 7.20e-03 | 19 | 135 | 2 | GO:0015373 | |
| GeneOntologyMolecularFunction | narrow pore channel activity | 7.20e-03 | 19 | 135 | 2 | GO:0022842 | |
| GeneOntologyMolecularFunction | leak channel activity | 7.20e-03 | 19 | 135 | 2 | GO:0022840 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated channel activity | 7.96e-03 | 20 | 135 | 2 | GO:0141147 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated chloride channel activity | 7.96e-03 | 20 | 135 | 2 | GO:0005229 | |
| GeneOntologyMolecularFunction | neurotransmitter transmembrane transporter activity | 8.76e-03 | 21 | 135 | 2 | GO:0005326 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1E SCN11A DRD1 SLC2A9 TRPC4 TRPC5 NPSR1 ANO10 PKD1L2 SLC30A4 CHRNB1 EDNRA SLC6A2 SLC6A4 ORAI1 SLC9A1 SLC46A3 SLC9A3 PIEZO2 KCNA5 ANO6 GLRB KCNK10 SCN10A SLC4A10 SLC9A7 ATP11C TMEM163 CCR5 KCNK17 TMEM109 STOM | 8.72e-13 | 1115 | 135 | 32 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1E SCN11A DRD1 SLC2A9 TRPC4 TRPC5 SLC22A15 NPSR1 ANO10 PKD1L2 SLC30A4 CHRNB1 EDNRA SLC5A11 SLC6A2 SLC6A4 ORAI1 SLC9A1 SLC46A3 SLC9A3 PIEZO2 KCNA5 ANO6 GLRB KCNK10 SCN10A SLC4A10 SLC9A7 ATP11C TMEM163 CCR5 KCNK17 TMEM109 STOM | 9.07e-12 | 1374 | 135 | 34 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1E SCN11A DRD1 SLC2A9 TRPC4 TRPC5 NPSR1 ANO10 PKD1L2 SLC30A4 EDNRA SLC6A2 SLC6A4 ORAI1 SLC9A1 SLC46A3 SLC9A3 PIEZO2 KCNA5 ANO6 KCNK10 SCN10A SLC4A10 SLC9A7 TMEM163 CCR5 KCNK17 TMEM109 | 1.33e-11 | 942 | 135 | 28 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1E SCN11A DRD1 SLC2A9 TRPC4 TRPC5 NPSR1 ANO10 PKD1L2 SLC30A4 CHRNB1 EDNRA SLC5A11 SLC6A2 SLC6A4 ORAI1 SLC9A1 SLC46A3 SLC9A3 PIEZO2 KCNA5 ANO6 KCNK10 SCN10A SLC4A10 SLC9A7 TMEM163 CCR5 KCNK17 TMEM109 | 6.39e-11 | 1157 | 135 | 30 | GO:0006812 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1E SCN11A DRD1 SLC2A9 SLC37A3 TRPC4 TRPC5 NPSR1 ANO10 PKD1L2 SLC30A4 EDNRA SLC6A2 SLC6A4 ORAI1 SLC9A1 SLC46A3 SLC9A3 KCNA5 ANO6 GLRB KCNK10 SCN10A SLC4A10 SLC9A7 TMEM163 CCR5 KCNK17 | 7.94e-11 | 1017 | 135 | 28 | GO:0098660 |
| GeneOntologyBiologicalProcess | lipid translocation | 1.88e-10 | 60 | 135 | 9 | GO:0034204 | |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 3.95e-10 | 65 | 135 | 9 | GO:0097035 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1E SCN11A DRD1 SLC2A9 TRPC4 TRPC5 NPSR1 PKD1L2 SLC30A4 EDNRA SLC6A2 SLC6A4 ORAI1 SLC9A1 SLC46A3 SLC9A3 KCNA5 ANO6 KCNK10 SCN10A SLC4A10 SLC9A7 TMEM163 CCR5 KCNK17 | 1.32e-09 | 922 | 135 | 25 | GO:0098662 |
| GeneOntologyBiologicalProcess | phospholipid translocation | 2.57e-09 | 55 | 135 | 8 | GO:0045332 | |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1E SCN11A DRD1 TRPC4 TRPC5 NPSR1 PKD1L2 SLC30A4 EDNRA SLC5A11 SLC6A2 SLC6A4 ORAI1 SLC9A1 SLC46A3 SLC9A3 KCNA5 ANO6 KCNK10 SCN10A SLC4A10 SLC9A7 TMEM163 CCR5 KCNK17 | 6.79e-09 | 1000 | 135 | 25 | GO:0030001 |
| GeneOntologyBiologicalProcess | organophosphate ester transport | ATP8B4 SLC37A3 TRPC5 XKR8 ATP9B XKR6 ATP9A ANO6 ATP11C SLC33A1 | 1.15e-07 | 162 | 135 | 10 | GO:0015748 |
| GeneOntologyBiologicalProcess | phospholipid transport | 4.81e-07 | 106 | 135 | 8 | GO:0015914 | |
| GeneOntologyBiologicalProcess | phosphatidylserine exposure on apoptotic cell surface | 8.34e-07 | 12 | 135 | 4 | GO:0070782 | |
| GeneOntologyBiologicalProcess | sodium ion transport | SCN11A EDNRA SLC5A11 SLC6A2 SLC6A4 SLC9A1 SLC9A3 ANO6 SCN10A SLC4A10 SLC9A7 | 2.01e-06 | 275 | 135 | 11 | GO:0006814 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR2A14 SCN11A DRD1 GPR19 OR2L3 NPSR1 MC1R P2RY13 LMBRD2 VN1R1 GPR139 EDNRA JAK2 OR2L2 ORAI1 TAS2R14 ADRB3 TAS2R5 OR10A4 GLRB OR10AD1 CCR4 CCR5 CCR6 HCRTR2 | 3.64e-06 | 1395 | 135 | 25 | GO:0007186 |
| GeneOntologyBiologicalProcess | behavior | CACNA1E SCN11A ABCA2 DRD1 CWH43 NPSR1 MC1R CHRNB1 SLC2A4 SLC6A4 ADRB3 TAS2R5 GLRB KCNK10 SCN10A SLC4A10 CSMD1 UNC79 HCRTR2 | 5.62e-06 | 891 | 135 | 19 | GO:0007610 |
| GeneOntologyBiologicalProcess | cellular homeostasis | CACNA1E ABCA2 DRD1 TRPC4 TRPC5 NPSR1 EDNRA DMXL1 SLC6A2 SIDT2 SLC9A1 SLC9A3 ZBED6 ANO6 SYPL2 PKHD1 SLC4A10 SLC9A7 CCR5 HCRTR2 | 6.07e-06 | 981 | 135 | 20 | GO:0019725 |
| GeneOntologyBiologicalProcess | chemical homeostasis | CACNA1E ABCA2 DRD1 ACACA TRPC4 TRPC5 NPSR1 EDNRA SLC2A4 DMXL1 SIDT2 SLC9A1 SLC9A3 KCNA5 ZBED6 NR5A2 SYPL2 PKHD1 SLC4A10 SLC9A7 CCR5 CSMD1 HCRTR2 | 6.10e-06 | 1249 | 135 | 23 | GO:0048878 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | SCN11A SLC6A2 SLC6A4 SLC9A1 SLC9A3 ANO6 SCN10A SLC4A10 SLC9A7 | 9.47e-06 | 208 | 135 | 9 | GO:0035725 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | CACNA1E SCN11A DRD1 TRPC4 TRPC5 NPSR1 PKD1L2 EDNRA ORAI1 SLC9A1 ANO6 CCR5 | 1.06e-05 | 392 | 135 | 12 | GO:0070588 |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | CACNA1E ABCA2 DRD1 TRPC4 TRPC5 NPSR1 EDNRA DMXL1 SIDT2 SLC9A1 SLC9A3 ZBED6 SYPL2 PKHD1 SLC4A10 SLC9A7 CCR5 HCRTR2 | 1.43e-05 | 866 | 135 | 18 | GO:0055082 |
| GeneOntologyBiologicalProcess | regulation of membrane potential | SCN11A DRD1 TRPC4 TRPC5 CHRNB1 SLC6A4 SLC9A1 PIEZO2 KCNA5 ANO6 GLRB KCNK10 SCN10A KCNK17 | 1.85e-05 | 559 | 135 | 14 | GO:0042391 |
| GeneOntologyBiologicalProcess | plasma membrane phospholipid scrambling | 2.35e-05 | 26 | 135 | 4 | GO:0017121 | |
| GeneOntologyBiologicalProcess | regulation of adenylate cyclase activity | 4.20e-05 | 59 | 135 | 5 | GO:0045761 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | DRD1 TRPC4 TRPC5 NPSR1 EDNRA DMXL1 SLC9A1 SLC9A3 SYPL2 PKHD1 SLC4A10 SLC9A7 CCR5 HCRTR2 | 4.89e-05 | 611 | 135 | 14 | GO:0030003 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | DRD1 TRPC4 TRPC5 NPSR1 EDNRA DMXL1 SLC9A1 SLC9A3 SYPL2 PKHD1 SLC4A10 SLC9A7 CCR5 HCRTR2 | 5.92e-05 | 622 | 135 | 14 | GO:0006873 |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | DRD1 TRPC4 TRPC5 NPSR1 EDNRA DMXL1 SLC9A1 SLC9A3 KCNA5 SYPL2 PKHD1 SLC4A10 SLC9A7 CCR5 HCRTR2 | 6.03e-05 | 705 | 135 | 15 | GO:0055080 |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | DRD1 TRPC4 TRPC5 NPSR1 EDNRA DMXL1 SLC9A1 SLC9A3 KCNA5 SYPL2 PKHD1 SLC4A10 SLC9A7 CCR5 HCRTR2 | 7.28e-05 | 717 | 135 | 15 | GO:0050801 |
| GeneOntologyBiologicalProcess | import into cell | CACNA1E ABCA2 DRD1 TBC1D2B XKR8 ATP9B XKR6 ATP9A SLC2A3 SLC2A4 SLC6A2 SLC6A4 SLC9A1 SLC9A3 ADRB3 ANO6 TSPO2 SYNGR3 SLC9A7 | 7.37e-05 | 1074 | 135 | 19 | GO:0098657 |
| GeneOntologyBiologicalProcess | activation of GTPase activity | 8.20e-05 | 109 | 135 | 6 | GO:0090630 | |
| GeneOntologyBiologicalProcess | regulation of cyclase activity | 8.96e-05 | 69 | 135 | 5 | GO:0031279 | |
| GeneOntologyBiologicalProcess | membrane organization | ABCA2 ATP8B4 TRPC5 XKR8 ATP9B XKR6 ATP9A CHRNB1 SLC2A4 SLC9A1 TRIM9 ANO6 GLRB SYNGR1 SYPL2 ATP11C TRAM2 | 1.00e-04 | 914 | 135 | 17 | GO:0061024 |
| GeneOntologyBiologicalProcess | regulation of lyase activity | 1.17e-04 | 73 | 135 | 5 | GO:0051339 | |
| GeneOntologyBiologicalProcess | calcium ion transport | CACNA1E SCN11A DRD1 TRPC4 TRPC5 NPSR1 PKD1L2 EDNRA ORAI1 SLC9A1 ANO6 CCR5 | 1.33e-04 | 509 | 135 | 12 | GO:0006816 |
| GeneOntologyBiologicalProcess | positive regulation of adenylate cyclase activity | 1.34e-04 | 40 | 135 | 4 | GO:0045762 | |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 2.26e-04 | 247 | 135 | 8 | GO:0009612 | |
| GeneOntologyBiologicalProcess | carbohydrate transport | 2.27e-04 | 186 | 135 | 7 | GO:0008643 | |
| GeneOntologyBiologicalProcess | zinc export across plasma membrane | 2.53e-04 | 4 | 135 | 2 | GO:0140882 | |
| GeneOntologyBiologicalProcess | protein kinase A signaling | 2.73e-04 | 48 | 135 | 4 | GO:0010737 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclase activity | 2.73e-04 | 48 | 135 | 4 | GO:0031281 | |
| GeneOntologyBiologicalProcess | positive regulation of lyase activity | 2.96e-04 | 49 | 135 | 4 | GO:0051349 | |
| GeneOntologyBiologicalProcess | circulatory system process | CACNA1E SCN11A ABCA2 DRD1 SLC2A3 EDNRA SLC2A4 TBC1D8 SLC6A4 SLC9A1 ADRB3 KCNA5 ASB3 SCN10A | 3.26e-04 | 733 | 135 | 14 | GO:0003013 |
| GeneOntologyBiologicalProcess | export across plasma membrane | 3.30e-04 | 91 | 135 | 5 | GO:0140115 | |
| GeneOntologyBiologicalProcess | response to pain | 3.46e-04 | 51 | 135 | 4 | GO:0048265 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transport | 3.72e-04 | 266 | 135 | 8 | GO:0043270 | |
| GeneOntologyBiologicalProcess | neurotransmitter uptake | 3.72e-04 | 52 | 135 | 4 | GO:0001504 | |
| GeneOntologyBiologicalProcess | secretion | CACNA1E DDR1 SCN11A CWH43 TRPC4 NPSR1 ATP9A EDNRA SLC6A4 JAK2 ORAI1 SIDT2 LLGL1 KCNA5 TRIM9 ZBED6 SYNGR3 SYNGR1 SV2C | 3.82e-04 | 1221 | 135 | 19 | GO:0046903 |
| GeneOntologyBiologicalProcess | regulation of intracellular pH | 3.84e-04 | 94 | 135 | 5 | GO:0051453 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | DRD1 TRPC4 NPSR1 EDNRA SLC6A4 ORAI1 SLC9A1 SLC9A3 KCNA5 ANO6 SCN10A STOM | 4.17e-04 | 577 | 135 | 12 | GO:0043269 |
| GeneOntologyBiologicalProcess | potassium ion transport | 4.32e-04 | 272 | 135 | 8 | GO:0006813 | |
| GeneOntologyBiologicalProcess | D-glucose transmembrane transport | 4.33e-04 | 148 | 135 | 6 | GO:1904659 | |
| GeneOntologyBiologicalProcess | hexose transmembrane transport | 4.82e-04 | 151 | 135 | 6 | GO:0008645 | |
| GeneOntologyBiologicalProcess | export from cell | CACNA1E SCN11A ATP9A SLC30A4 SLC6A4 JAK2 ORAI1 SIDT2 SLC9A1 LLGL1 KCNA5 TRIM9 ZBED6 ANO6 SYNGR3 SYNGR1 SV2C TMEM163 | 5.30e-04 | 1153 | 135 | 18 | GO:0140352 |
| GeneOntologyBiologicalProcess | regulation of cellular pH | 5.34e-04 | 101 | 135 | 5 | GO:0030641 | |
| GeneOntologyBiologicalProcess | monosaccharide transmembrane transport | 5.35e-04 | 154 | 135 | 6 | GO:0015749 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport | 5.35e-04 | 154 | 135 | 6 | GO:0051928 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 6.06e-04 | 359 | 135 | 9 | GO:0006874 | |
| GeneOntologyBiologicalProcess | conditioned place preference | 6.27e-04 | 6 | 135 | 2 | GO:1990708 | |
| GeneOntologyBiologicalProcess | synaptic signaling | CACNA1E DRD1 SYNPR CHRNB1 SLC6A2 SLC6A4 JAK2 ORAI1 TRIM9 SYNGR3 GLRB SYNGR1 SLC4A10 SYPL1 SV2C HCRTR2 | 6.55e-04 | 976 | 135 | 16 | GO:0099536 |
| GeneOntologyBiologicalProcess | feeding behavior | 6.98e-04 | 162 | 135 | 6 | GO:0007631 | |
| GeneOntologyBiologicalProcess | sodium ion import across plasma membrane | 7.15e-04 | 27 | 135 | 3 | GO:0098719 | |
| GeneOntologyBiologicalProcess | carbohydrate transmembrane transport | 8.44e-04 | 168 | 135 | 6 | GO:0034219 | |
| GeneOntologyBiologicalProcess | potassium ion transmembrane transport | 8.52e-04 | 232 | 135 | 7 | GO:0071805 | |
| GeneOntologyBiologicalProcess | bundle of His cell action potential | 8.74e-04 | 7 | 135 | 2 | GO:0086043 | |
| GeneOntologyBiologicalProcess | bundle of His cell to Purkinje myocyte signaling | 8.74e-04 | 7 | 135 | 2 | GO:0086028 | |
| GeneOntologyBiologicalProcess | dendritic cell chemotaxis | 8.85e-04 | 29 | 135 | 3 | GO:0002407 | |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | 1.07e-03 | 389 | 135 | 9 | GO:0055074 | |
| GeneOntologyBiologicalProcess | reflex | 1.08e-03 | 31 | 135 | 3 | GO:0060004 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | CACNA1E DRD1 SYNPR CHRNB1 SLC6A2 SLC6A4 JAK2 TRIM9 SYNGR3 GLRB SYNGR1 SLC4A10 SYPL1 SV2C HCRTR2 | 1.16e-03 | 931 | 135 | 15 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | CACNA1E DRD1 SYNPR CHRNB1 SLC6A2 SLC6A4 JAK2 TRIM9 SYNGR3 GLRB SYNGR1 SLC4A10 SYPL1 SV2C HCRTR2 | 1.16e-03 | 931 | 135 | 15 | GO:0007268 |
| GeneOntologyBiologicalProcess | vacuolar transmembrane transport | 1.16e-03 | 8 | 135 | 2 | GO:0034486 | |
| GeneOntologyBiologicalProcess | regulation of pH | 1.16e-03 | 120 | 135 | 5 | GO:0006885 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 1.18e-03 | 32 | 135 | 3 | GO:0048266 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 1.21e-03 | 180 | 135 | 6 | GO:0015698 | |
| GeneOntologyBiologicalProcess | lipid localization | SMIM22 ABCA2 ATP8B4 TRPC5 XKR8 ATP9B XKR6 ATP9A ANO6 TSPO2 ATP11C | 1.24e-03 | 565 | 135 | 11 | GO:0010876 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | CACNA1E DRD1 SYNPR CHRNB1 SLC6A2 SLC6A4 JAK2 TRIM9 SYNGR3 GLRB SYNGR1 SLC4A10 SYPL1 SV2C HCRTR2 | 1.26e-03 | 939 | 135 | 15 | GO:0099537 |
| GeneOntologyBiologicalProcess | activation of adenylate cyclase activity | 1.41e-03 | 34 | 135 | 3 | GO:0007190 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 1.45e-03 | 126 | 135 | 5 | GO:0033555 | |
| GeneOntologyBiologicalProcess | dehydroascorbic acid transport | 1.49e-03 | 9 | 135 | 2 | GO:0070837 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 1.49e-03 | 75 | 135 | 4 | GO:0050982 | |
| GeneOntologyBiologicalProcess | synaptic transmission, dopaminergic | 1.54e-03 | 35 | 135 | 3 | GO:0001963 | |
| GeneOntologyBiologicalProcess | adrenergic receptor signaling pathway | 1.54e-03 | 35 | 135 | 3 | GO:0071875 | |
| GeneOntologyCellularComponent | transporter complex | CACNA1E SCN11A ABCA2 ATP8B4 TRPC4 TRPC5 CHRNB1 ORAI1 SLC9A1 KCNA5 ANO6 GLRB KCNK10 SCN10A ATP11C KCNK17 TMEM109 | 1.24e-07 | 550 | 137 | 17 | GO:1990351 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CACNA1E SCN11A TRPC4 TRPC5 CHRNB1 ORAI1 KCNA5 ANO6 GLRB KCNK10 SCN10A KCNK17 TMEM109 | 1.27e-06 | 378 | 137 | 13 | GO:0034702 |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA1E SCN11A ABCA2 TRPC4 TRPC5 CHRNB1 ORAI1 SLC9A1 KCNA5 ANO6 GLRB KCNK10 SCN10A KCNK17 TMEM109 | 1.82e-06 | 523 | 137 | 15 | GO:1902495 |
| GeneOntologyCellularComponent | membrane raft | PAG1 DRD1 TRPC4 SLC2A3 SLC2A4 SLC6A4 JAK2 ORAI1 SLC9A1 KCNA5 IL6ST STOM | 4.84e-06 | 362 | 137 | 12 | GO:0045121 |
| GeneOntologyCellularComponent | membrane microdomain | PAG1 DRD1 TRPC4 SLC2A3 SLC2A4 SLC6A4 JAK2 ORAI1 SLC9A1 KCNA5 IL6ST STOM | 5.12e-06 | 364 | 137 | 12 | GO:0098857 |
| GeneOntologyCellularComponent | lysosomal membrane | ABCA2 SLC37A3 DRAM1 DRAM2 SLC30A4 SIDT2 SLC46A3 WDR11 SYNGR1 ATP11C TMEM163 MMD STOM | 1.13e-05 | 462 | 137 | 13 | GO:0005765 |
| GeneOntologyCellularComponent | lytic vacuole membrane | ABCA2 SLC37A3 DRAM1 DRAM2 SLC30A4 SIDT2 SLC46A3 WDR11 SYNGR1 ATP11C TMEM163 MMD STOM | 1.13e-05 | 462 | 137 | 13 | GO:0098852 |
| GeneOntologyCellularComponent | presynapse | CACNA1E SCN11A DRD1 TRPC5 SYNPR SLC2A3 SLC2A4 SLC6A2 SLC6A4 TRIM9 SYNGR3 SYNGR1 SYPL2 SCN10A SLC4A10 SYPL1 SV2C TMEM163 | 2.00e-05 | 886 | 137 | 18 | GO:0098793 |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 2.41e-05 | 179 | 137 | 8 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 2.41e-05 | 179 | 137 | 8 | GO:0030672 | |
| GeneOntologyCellularComponent | vacuolar membrane | ABCA2 SLC37A3 DRAM1 DRAM2 SLC30A4 SIDT2 SLC46A3 WDR11 SYNGR1 ATP11C TMEM163 MMD STOM | 2.99e-05 | 507 | 137 | 13 | GO:0005774 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | ABCA2 ATP8B4 ATP9A SLC30A4 SYNPR SLC2A3 SLC2A4 SLC6A4 SLC9A3 LLGL1 ANO6 SYNGR3 SYNGR1 SYPL2 SLC9A7 SYPL1 SV2C ATP11C TMEM163 TMEM225 MMD STOM | 4.09e-05 | 1307 | 137 | 22 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | ABCA2 ATP8B4 ATP9A SLC30A4 SYNPR SLC2A3 SLC2A4 SLC6A4 SLC9A3 LLGL1 ANO6 SYNGR3 SYNGR1 SYPL2 SLC9A7 SYPL1 SV2C ATP11C TMEM163 TMEM225 MMD STOM | 5.02e-05 | 1325 | 137 | 22 | GO:0012506 |
| GeneOntologyCellularComponent | synaptic vesicle | 1.65e-04 | 300 | 137 | 9 | GO:0008021 | |
| GeneOntologyCellularComponent | C-fiber | 2.54e-04 | 4 | 137 | 2 | GO:0044299 | |
| GeneOntologyCellularComponent | exocytic vesicle | 2.66e-04 | 320 | 137 | 9 | GO:0070382 | |
| GeneOntologyCellularComponent | lysosome | ABCA2 SLC37A3 DRAM1 DRAM2 SLC30A4 ADA2 SIDT2 SLC46A3 WDR11 SYNGR1 ATP11C TMEM163 MMD STOM WDR48 | 2.85e-04 | 811 | 137 | 15 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | ABCA2 SLC37A3 DRAM1 DRAM2 SLC30A4 ADA2 SIDT2 SLC46A3 WDR11 SYNGR1 ATP11C TMEM163 MMD STOM WDR48 | 2.85e-04 | 811 | 137 | 15 | GO:0000323 |
| GeneOntologyCellularComponent | plasma membrane raft | 4.21e-04 | 147 | 137 | 6 | GO:0044853 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 7.11e-04 | 293 | 137 | 8 | GO:0030658 | |
| GeneOntologyCellularComponent | caveola | 8.26e-04 | 111 | 137 | 5 | GO:0005901 | |
| GeneOntologyCellularComponent | cation channel complex | 9.26e-04 | 235 | 137 | 7 | GO:0034703 | |
| GeneOntologyCellularComponent | vacuole | ABCA2 SLC37A3 DRAM1 DRAM2 SLC30A4 ADA2 SIDT2 SLC46A3 WDR11 SYNGR1 ATP11C TMEM163 MMD STOM WDR48 | 9.68e-04 | 913 | 137 | 15 | GO:0005773 |
| GeneOntologyCellularComponent | tertiary granule membrane | 1.35e-03 | 73 | 137 | 4 | GO:0070821 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.35e-03 | 73 | 137 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | endosome | SMIM22 ABCA2 TBC1D2B ATP9B ATP9A SLC30A4 SLC2A4 SLC6A4 JAK2 SLC9A3 LLGL1 SLC9A7 ATP11C TMEM163 CCR5 MMD WDR48 | 1.65e-03 | 1167 | 137 | 17 | GO:0005768 |
| GeneOntologyCellularComponent | T-tubule | 1.81e-03 | 79 | 137 | 4 | GO:0030315 | |
| GeneOntologyCellularComponent | transport vesicle | SYNPR SLC2A3 SLC2A4 TRIM9 SYNGR3 SYNGR1 SYPL2 SYPL1 SV2C TMEM163 | 2.25e-03 | 519 | 137 | 10 | GO:0030133 |
| GeneOntologyCellularComponent | cell surface | DRD1 TRPC4 SLC2A4 SLC6A2 SLC9A1 SLC9A3 KCNA5 ANO6 GLRB PKHD1 CCR4 ROS1 CCR5 CCR6 IL6ST FGFBP1 | 2.54e-03 | 1111 | 137 | 16 | GO:0009986 |
| GeneOntologyCellularComponent | specific granule membrane | 3.04e-03 | 91 | 137 | 4 | GO:0035579 | |
| GeneOntologyCellularComponent | secretory vesicle | ATP8B4 FN1 ADA2 SYNPR SLC2A3 SLC2A4 TRIM9 ANO6 MROH2B SYNGR3 SYNGR1 SYPL2 SYPL1 SV2C TMEM163 TMEM225 STOM | 3.26e-03 | 1246 | 137 | 17 | GO:0099503 |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 3.68e-03 | 14 | 137 | 2 | GO:1990531 | |
| GeneOntologyCellularComponent | trans-Golgi network | 4.10e-03 | 306 | 137 | 7 | GO:0005802 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | RNF121 PIGN DRD1 SLC37A3 ZDHHC14 TMEM39B ERMP1 EXTL1 TRIM59 AWAT2 HHATL OR10A4 TSPO2 ATP11C TMEM109 TRAM2 SLC33A1 | 4.73e-03 | 1293 | 137 | 17 | GO:0005789 |
| GeneOntologyCellularComponent | apical plasma membrane | 4.86e-03 | 487 | 137 | 9 | GO:0016324 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | RNF121 PIGN DRD1 SLC37A3 ZDHHC14 TMEM39B ERMP1 EXTL1 TRIM59 AWAT2 HHATL OR10A4 TSPO2 ATP11C TMEM109 TRAM2 SLC33A1 | 4.95e-03 | 1299 | 137 | 17 | GO:0098827 |
| GeneOntologyCellularComponent | synaptic membrane | CACNA1E SCN11A DRD1 SLC2A3 CHRNB1 SLC6A2 SLC6A4 ANO6 GLRB SCN10A | 5.12e-03 | 583 | 137 | 10 | GO:0097060 |
| GeneOntologyCellularComponent | basolateral plasma membrane | 5.22e-03 | 320 | 137 | 7 | GO:0016323 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 5.44e-03 | 17 | 137 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | RNF121 PIGN DRD1 SLC37A3 ZDHHC14 TMEM39B ERMP1 EXTL1 TRIM59 AWAT2 HHATL OR10A4 TSPO2 ATP11C TMEM109 TRAM2 SLC33A1 | 6.10e-03 | 1327 | 137 | 17 | GO:0042175 |
| GeneOntologyCellularComponent | recycling endosome membrane | 6.35e-03 | 112 | 137 | 4 | GO:0055038 | |
| GeneOntologyCellularComponent | endosome membrane | ABCA2 ATP9A SLC30A4 SLC6A4 SLC9A3 LLGL1 SLC9A7 ATP11C TMEM163 MMD | 6.37e-03 | 602 | 137 | 10 | GO:0010008 |
| MousePheno | abnormal channel response intensity | 1.62e-05 | 7 | 110 | 3 | MP:0003486 | |
| Domain | MARVEL | 1.35e-06 | 27 | 136 | 5 | PF01284 | |
| Domain | Synaptophysin/porin | 1.50e-06 | 4 | 136 | 3 | IPR001285 | |
| Domain | Marvel | 1.63e-06 | 28 | 136 | 5 | IPR008253 | |
| Domain | MARVEL | 1.63e-06 | 28 | 136 | 5 | PS51225 | |
| Domain | GPCR_Rhodpsn_7TM | OR2A14 DRD1 GPR19 OR2L3 NPSR1 MC1R P2RY13 VN1R1 GPR139 EDNRA OR2L2 ADRB3 OR10A4 OR10AD1 CCR4 CCR5 CCR6 HCRTR2 | 1.81e-06 | 670 | 136 | 18 | IPR017452 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR2A14 DRD1 GPR19 OR2L3 NPSR1 MC1R P2RY13 VN1R1 GPR139 EDNRA OR2L2 ADRB3 OR10A4 OR10AD1 CCR4 CCR5 CCR6 HCRTR2 | 2.47e-06 | 685 | 136 | 18 | PS00237 |
| Domain | P_typ_ATPase_c | 2.54e-06 | 14 | 136 | 4 | IPR032630 | |
| Domain | P-type_ATPase_N | 2.54e-06 | 14 | 136 | 4 | IPR032631 | |
| Domain | P-type_ATPase_IV | 2.54e-06 | 14 | 136 | 4 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 2.54e-06 | 14 | 136 | 4 | PF16212 | |
| Domain | PhoLip_ATPase_N | 2.54e-06 | 14 | 136 | 4 | PF16209 | |
| Domain | G_PROTEIN_RECEP_F1_2 | OR2A14 DRD1 GPR19 OR2L3 NPSR1 MC1R P2RY13 VN1R1 GPR139 EDNRA OR2L2 ADRB3 OR10A4 OR10AD1 CCR4 CCR5 CCR6 HCRTR2 | 2.79e-06 | 691 | 136 | 18 | PS50262 |
| Domain | GPCR_Rhodpsn | OR2A14 DRD1 GPR19 OR2L3 NPSR1 MC1R P2RY13 VN1R1 GPR139 EDNRA OR2L2 ADRB3 OR10A4 OR10AD1 CCR4 CCR5 CCR6 HCRTR2 | 2.84e-06 | 692 | 136 | 18 | IPR000276 |
| Domain | MFS_sugar_transport-like | 5.98e-06 | 36 | 136 | 5 | IPR005828 | |
| Domain | Sugar_tr | 5.98e-06 | 36 | 136 | 5 | PF00083 | |
| Domain | MFS_dom | 6.20e-06 | 134 | 136 | 8 | IPR020846 | |
| Domain | 7tm_1 | OR2A14 DRD1 GPR19 OR2L3 NPSR1 MC1R P2RY13 GPR139 EDNRA OR2L2 ADRB3 OR10A4 OR10AD1 CCR4 CCR5 CCR6 HCRTR2 | 8.73e-06 | 677 | 136 | 17 | PF00001 |
| Domain | MFS | 1.41e-05 | 108 | 136 | 7 | PS50850 | |
| Domain | fn3 | 2.48e-05 | 162 | 136 | 8 | PF00041 | |
| Domain | TBC | 2.80e-05 | 49 | 136 | 5 | SM00164 | |
| Domain | NaH_exchanger | 3.07e-05 | 9 | 136 | 3 | IPR004709 | |
| Domain | RabGAP-TBC | 4.12e-05 | 53 | 136 | 5 | PF00566 | |
| Domain | TBC_RABGAP | 4.94e-05 | 55 | 136 | 5 | PS50086 | |
| Domain | Rab-GTPase-TBC_dom | 4.94e-05 | 55 | 136 | 5 | IPR000195 | |
| Domain | Cation/H_exchanger_CPA1 | 5.97e-05 | 11 | 136 | 3 | IPR018422 | |
| Domain | FN3 | 6.37e-05 | 185 | 136 | 8 | SM00060 | |
| Domain | Sugar_transporter_CS | 8.26e-05 | 32 | 136 | 4 | IPR005829 | |
| Domain | - | 8.26e-05 | 32 | 136 | 4 | 3.40.1110.10 | |
| Domain | - | 8.26e-05 | 32 | 136 | 4 | 2.70.150.10 | |
| Domain | FN3 | 1.06e-04 | 199 | 136 | 8 | PS50853 | |
| Domain | ATPase_P-typ_cyto_domN | 1.18e-04 | 35 | 136 | 4 | IPR023299 | |
| Domain | Na_H_Exchanger | 1.30e-04 | 14 | 136 | 3 | PF00999 | |
| Domain | Cation/H_exchanger | 1.30e-04 | 14 | 136 | 3 | IPR006153 | |
| Domain | Sugar/inositol_transpt | 1.30e-04 | 14 | 136 | 3 | IPR003663 | |
| Domain | P_typ_ATPase | 1.32e-04 | 36 | 136 | 4 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 1.32e-04 | 36 | 136 | 4 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 1.32e-04 | 36 | 136 | 4 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.47e-04 | 37 | 136 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.47e-04 | 37 | 136 | 4 | PF00122 | |
| Domain | FN3_dom | 1.49e-04 | 209 | 136 | 8 | IPR003961 | |
| Domain | WD40 | 1.55e-04 | 268 | 136 | 9 | SM00320 | |
| Domain | ATII_AT1_rcpt | 1.57e-04 | 3 | 136 | 2 | IPR000190 | |
| Domain | 7TM_GPCR_Srsx | 1.70e-04 | 112 | 136 | 6 | SM01381 | |
| Domain | WD40_repeat | 1.73e-04 | 272 | 136 | 9 | IPR001680 | |
| Domain | Ion_trans_dom | 1.87e-04 | 114 | 136 | 6 | IPR005821 | |
| Domain | Ion_trans | 1.87e-04 | 114 | 136 | 6 | PF00520 | |
| Domain | GRAM | 1.97e-04 | 16 | 136 | 3 | SM00568 | |
| Domain | Chemokine_rcpt | 1.97e-04 | 16 | 136 | 3 | IPR000355 | |
| Domain | WD40_repeat_CS | 2.00e-04 | 164 | 136 | 7 | IPR019775 | |
| Domain | WD_REPEATS_1 | 2.03e-04 | 278 | 136 | 9 | PS00678 | |
| Domain | WD_REPEATS_2 | 2.09e-04 | 279 | 136 | 9 | PS50082 | |
| Domain | WD_REPEATS_REGION | 2.09e-04 | 279 | 136 | 9 | PS50294 | |
| Domain | SUGAR_TRANSPORT_2 | 2.38e-04 | 17 | 136 | 3 | PS00217 | |
| Domain | Synaptogyrin | 3.13e-04 | 4 | 136 | 2 | IPR016579 | |
| Domain | WD40_repeat_dom | 3.31e-04 | 297 | 136 | 9 | IPR017986 | |
| Domain | GRAM | 5.26e-04 | 22 | 136 | 3 | PF02893 | |
| Domain | GRAM | 5.26e-04 | 22 | 136 | 3 | IPR004182 | |
| Domain | WD40 | 6.27e-04 | 259 | 136 | 8 | PF00400 | |
| Domain | SUGAR_TRANSPORT_1 | 6.83e-04 | 24 | 136 | 3 | PS00216 | |
| Domain | - | 7.54e-04 | 333 | 136 | 9 | 2.130.10.10 | |
| Domain | TRP_dom | 7.75e-04 | 6 | 136 | 2 | IPR013555 | |
| Domain | TRP_2 | 7.75e-04 | 6 | 136 | 2 | PF08344 | |
| Domain | Frag1 | 7.75e-04 | 6 | 136 | 2 | PF10277 | |
| Domain | Frag1/DRAM/Sfk1 | 7.75e-04 | 6 | 136 | 2 | IPR019402 | |
| Domain | WD40/YVTN_repeat-like_dom | 7.86e-04 | 335 | 136 | 9 | IPR015943 | |
| Domain | Channel_four-helix_dom | 7.88e-04 | 57 | 136 | 4 | IPR027359 | |
| Domain | - | 7.88e-04 | 57 | 136 | 4 | 1.20.120.350 | |
| Domain | TRPC_channel | 1.08e-03 | 7 | 136 | 2 | IPR002153 | |
| Domain | - | 1.22e-03 | 64 | 136 | 4 | 3.40.50.1000 | |
| Domain | DHC_N1 | 1.43e-03 | 8 | 136 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.43e-03 | 8 | 136 | 2 | IPR013594 | |
| Domain | Na_channel_asu | 2.28e-03 | 10 | 136 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 2.28e-03 | 10 | 136 | 2 | IPR010526 | |
| Domain | Anoctamin | 2.28e-03 | 10 | 136 | 2 | PF04547 | |
| Domain | Anoctamin | 2.28e-03 | 10 | 136 | 2 | IPR007632 | |
| Domain | Na_trans_assoc | 2.28e-03 | 10 | 136 | 2 | PF06512 | |
| Domain | HAD-like_dom | 2.65e-03 | 79 | 136 | 4 | IPR023214 | |
| Domain | TRP_channel | 2.77e-03 | 11 | 136 | 2 | IPR004729 | |
| Domain | - | 2.77e-03 | 11 | 136 | 2 | 1.20.1510.10 | |
| Domain | Cation_efflux_TMD | 2.77e-03 | 11 | 136 | 2 | IPR027469 | |
| Domain | XK_rel | 2.77e-03 | 11 | 136 | 2 | IPR018629 | |
| Domain | Tyr_kinase_rcpt_2_CS | 2.77e-03 | 11 | 136 | 2 | IPR002011 | |
| Domain | XK-related | 2.77e-03 | 11 | 136 | 2 | PF09815 | |
| Domain | RECEPTOR_TYR_KIN_II | 3.31e-03 | 12 | 136 | 2 | PS00239 | |
| Domain | TyrKc | 3.91e-03 | 88 | 136 | 4 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 3.91e-03 | 88 | 136 | 4 | IPR020635 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.52e-03 | 14 | 136 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.52e-03 | 14 | 136 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.52e-03 | 14 | 136 | 2 | IPR013602 | |
| Domain | DHC_N2 | 4.52e-03 | 14 | 136 | 2 | PF08393 | |
| Domain | MT | 4.52e-03 | 14 | 136 | 2 | PF12777 | |
| Domain | AAA_8 | 4.52e-03 | 14 | 136 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 4.52e-03 | 14 | 136 | 2 | IPR011704 | |
| Domain | AAA_5 | 4.52e-03 | 14 | 136 | 2 | PF07728 | |
| Domain | DHC_fam | 5.19e-03 | 15 | 136 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 5.19e-03 | 15 | 136 | 2 | IPR004273 | |
| Domain | 2pore_dom_K_chnl | 5.19e-03 | 15 | 136 | 2 | IPR003280 | |
| Domain | Dynein_heavy | 5.19e-03 | 15 | 136 | 2 | PF03028 | |
| Domain | PROTEIN_KINASE_TYR | 5.53e-03 | 97 | 136 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 5.53e-03 | 97 | 136 | 4 | IPR008266 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCA2 ATP8B4 SLC2A9 TRPC4 TRPC5 SLC22A15 ATP9B ANO10 ATP9A SLC2A3 SLC2A4 SLC5A11 SLC6A2 SLC9A1 SLC9A3 ANO6 SLC4A10 SLC9A7 ATP11C UNC79 SLC33A1 STOM | 2.48e-09 | 681 | 102 | 22 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCA2 ATP8B4 SLC2A9 TRPC4 TRPC5 SLC22A15 ATP9B ANO10 ATP9A SLC2A3 SLC2A4 SLC5A11 SLC6A2 SLC9A1 SLC9A3 ANO6 SLC4A10 SLC9A7 ATP11C UNC79 SLC33A1 STOM | 1.03e-08 | 736 | 102 | 22 | M27287 |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 5.63e-07 | 176 | 102 | 10 | MM15718 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 8.06e-07 | 183 | 102 | 10 | M997 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC2A9 SLC22A15 SLC2A3 SLC2A4 SLC5A11 SLC6A2 SLC9A1 SLC9A3 SLC4A10 SLC9A7 SLC33A1 | 1.16e-06 | 238 | 102 | 11 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC2A9 SLC22A15 SLC2A3 SLC2A4 SLC5A11 SLC6A2 SLC9A1 SLC9A3 SLC4A10 SLC9A7 SLC33A1 | 1.81e-06 | 249 | 102 | 11 | M5988 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | DRD1 GPR19 MC1R P2RY13 EDNRA ADRB3 OR10A4 CCR4 CCR5 CCR6 HCRTR2 | 2.75e-06 | 260 | 102 | 11 | M39397 |
| Pathway | WP_PEPTIDE_GPCRS | 1.66e-05 | 75 | 102 | 6 | M39696 | |
| Pathway | WP_GPCRS_NONODORANT | 2.24e-05 | 266 | 102 | 10 | MM15843 | |
| Pathway | REACTOME_SODIUM_PROTON_EXCHANGERS | 2.99e-05 | 9 | 102 | 3 | M27337 | |
| Pathway | REACTOME_SODIUM_PROTON_EXCHANGERS | 2.99e-05 | 9 | 102 | 3 | MM15079 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 6.02e-05 | 186 | 102 | 8 | MM15994 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 8.05e-05 | 99 | 102 | 6 | MM14910 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 1.18e-04 | 106 | 102 | 6 | M27200 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | DRD1 NPSR1 MC1R P2RY13 EDNRA TAS2R14 ADRB3 TAS2R5 CCR4 CCR5 CCR6 HCRTR2 | 1.27e-04 | 463 | 102 | 12 | M507 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 1.36e-04 | 330 | 102 | 10 | M18334 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 1.47e-04 | 333 | 102 | 10 | MM14963 | |
| Pathway | WP_GPCRS_PEPTIDE | 1.50e-04 | 70 | 102 | 5 | MM15959 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | DRD1 NPSR1 MC1R P2RY13 EDNRA TAS2R14 ADRB3 CCR4 CCR5 CCR6 HCRTR2 | 2.75e-04 | 430 | 102 | 11 | MM15160 |
| Pathway | REACTOME_CELLULAR_HEXOSE_TRANSPORT | 3.28e-04 | 19 | 102 | 3 | MM14718 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 3.58e-04 | 130 | 102 | 6 | M27454 | |
| Pathway | REACTOME_CELLULAR_HEXOSE_TRANSPORT | 4.45e-04 | 21 | 102 | 3 | M27058 | |
| Pathway | WP_NRF2_PATHWAY | 5.52e-04 | 141 | 102 | 6 | M39454 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 5.64e-04 | 197 | 102 | 7 | M12289 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 5.64e-04 | 197 | 102 | 7 | MM14970 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 6.64e-04 | 55 | 102 | 4 | M971 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 7.60e-04 | 57 | 102 | 4 | MM15643 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 7.94e-04 | 272 | 102 | 8 | M13380 | |
| Pathway | PID_ENDOTHELIN_PATHWAY | 1.11e-03 | 63 | 102 | 4 | M8 | |
| Pathway | REACTOME_MAPK1_ERK2_ACTIVATION | 1.41e-03 | 8 | 102 | 2 | MM14507 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | DRD1 FN1 NPSR1 MC1R P2RY13 EDNRA TAS2R14 ADRB3 TAS2R5 CCR4 CCR5 CCR6 HCRTR2 | 1.62e-03 | 702 | 102 | 13 | M746 |
| Pathway | REACTOME_MAPK3_ERK1_ACTIVATION | 1.81e-03 | 9 | 102 | 2 | MM14474 | |
| Pathway | REACTOME_INTERLEUKIN_6_SIGNALING | 1.81e-03 | 9 | 102 | 2 | MM14470 | |
| Pathway | REACTOME_INTERLEUKIN_35_SIGNALLING | 1.81e-03 | 9 | 102 | 2 | MM15580 | |
| Pathway | REACTOME_MAPK1_ERK2_ACTIVATION | 1.81e-03 | 9 | 102 | 2 | M26918 | |
| Pathway | REACTOME_INTERLEUKIN_27_SIGNALING | 1.81e-03 | 9 | 102 | 2 | MM15620 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | 1.98e-03 | 314 | 102 | 8 | M39428 | |
| Pathway | REACTOME_MAPK3_ERK1_ACTIVATION | 2.25e-03 | 10 | 102 | 2 | M26896 | |
| Pathway | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING | 2.25e-03 | 10 | 102 | 2 | M27330 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | DRD1 FN1 NPSR1 MC1R P2RY13 EDNRA TAS2R14 ADRB3 CCR4 CCR5 CCR6 HCRTR2 | 2.40e-03 | 646 | 102 | 12 | MM14962 |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | DDR1 DRAM2 ERMP1 LMBRD2 TRIM59 SLC35F5 TBC1D8 JAK2 ORAI1 SLC9A1 TRIM9 ANO6 SYNGR3 NR5A2 SLC4A10 SYPL1 ATP11C SGSM3 SLC33A1 IL6ST | 8.25e-09 | 1061 | 138 | 20 | 33845483 |
| Pubmed | Differential expression of putative transbilayer amphipath transporters. | 1.65e-07 | 13 | 138 | 4 | 11015572 | |
| Pubmed | Elevated synaptic vesicle release probability in synaptophysin/gyrin family quadruple knockouts. | 6.08e-07 | 5 | 138 | 3 | 31090538 | |
| Pubmed | 2.11e-06 | 7 | 138 | 3 | 23575686 | ||
| Pubmed | 5.05e-06 | 9 | 138 | 3 | 12070001 | ||
| Pubmed | 5.05e-06 | 9 | 138 | 3 | 22683701 | ||
| Pubmed | 7.19e-06 | 10 | 138 | 3 | 15919184 | ||
| Pubmed | Association study of 182 candidate genes in anorexia nervosa. | 8.71e-06 | 182 | 138 | 7 | 20468064 | |
| Pubmed | 1.31e-05 | 12 | 138 | 3 | 21914794 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 15337646 | ||
| Pubmed | Heat-resistant action potentials require TTX-resistant sodium channels NaV1.8 and NaV1.9. | 1.56e-05 | 2 | 138 | 2 | 29970412 | |
| Pubmed | Unravelling neurotransmitters impairment in primary progressive aphasias. | 1.56e-05 | 2 | 138 | 2 | 36649260 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 25650523 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 24144460 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 18305139 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 37373335 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 18511195 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23485472 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 15591779 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 20491280 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 28986537 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 28450535 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23159814 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23565250 | ||
| Pubmed | Mammalian Glucose Transporter Activity Is Dependent upon Anionic and Conical Phospholipids. | 1.56e-05 | 2 | 138 | 2 | 27302065 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 19468717 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 22457348 | ||
| Pubmed | Norepinephrine and serotonin transporter genes: impact on treatment response in depression. | 1.56e-05 | 2 | 138 | 2 | 20588071 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 31534133 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23677990 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 22876578 | ||
| Pubmed | Involvement of TRPC4 and 5 Channels in Persistent Firing in Hippocampal CA1 Pyramidal Cells. | 1.56e-05 | 2 | 138 | 2 | 32033274 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 21129446 | ||
| Pubmed | Up-regulation of CCR5 and CCR6 on distinct subpopulations of antigen-activated CD4+ T lymphocytes. | 1.56e-05 | 2 | 138 | 2 | 11751947 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23313574 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 17624425 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23086945 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 19369449 | ||
| Pubmed | Cryptic domains of tenascin-C differentially control fibronectin fibrillogenesis. | 1.56e-05 | 2 | 138 | 2 | 20708078 | |
| Pubmed | Binding of tenascin-C to soluble fibronectin and matrix fibrils. | 1.56e-05 | 2 | 138 | 2 | 7499434 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 25295552 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 34899056 | ||
| Pubmed | Corticolimbic expression of TRPC4 and TRPC5 channels in the rodent brain. | 1.56e-05 | 2 | 138 | 2 | 17593972 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 18399542 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 30049187 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 19556885 | ||
| Pubmed | Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma. | 1.56e-05 | 2 | 138 | 2 | 30451798 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 28339658 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 26317356 | ||
| Pubmed | Effects of duloxetine on norepinephrine and serotonin transporter activity in healthy subjects. | 1.56e-05 | 2 | 138 | 2 | 24346757 | |
| Pubmed | A novel capacitative calcium entry channel expressed in excitable cells. | 1.56e-05 | 2 | 138 | 2 | 9687496 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 9482226 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 24632207 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 20017301 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 22490506 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 19931571 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 24792713 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 34930944 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 16857712 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 27132989 | ||
| Pubmed | Getting to the Outer Leaflet: Physiology of Phosphatidylserine Exposure at the Plasma Membrane. | 1.56e-05 | 2 | 138 | 2 | 26936867 | |
| Pubmed | Role of Ca(2+) in the Stability and Function of TMEM16F and 16K. | 1.56e-05 | 2 | 138 | 2 | 27227820 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 8034131 | ||
| Pubmed | The Nav1.9 channel is a key determinant of cold pain sensation and cold allodynia. | 1.56e-05 | 2 | 138 | 2 | 25959819 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 22740348 | ||
| Pubmed | Reduced expression of DRAM2/TMEM77 in tumor cells interferes with cell death. | 1.56e-05 | 2 | 138 | 2 | 19895784 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 20232238 | ||
| Pubmed | The importance of CCR4 and CCR6 in experimental autoimmune encephalomyelitis. | 1.56e-05 | 2 | 138 | 2 | 23477966 | |
| Pubmed | TRPC4/TRPC5 channels mediate adverse reaction to the cancer cell cytotoxic agent (-)-Englerin A. | 1.56e-05 | 2 | 138 | 2 | 30038709 | |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | ABCA2 NPSR1 OBSL1 ANO10 ATP9A HHATL LLGL1 SLC9A7 CCR4 CCR5 CCR6 SGSM3 | 2.34e-05 | 697 | 138 | 12 | 28298427 |
| Pubmed | Functional dissection of Rab GTPases involved in primary cilium formation. | 2.60e-05 | 43 | 138 | 4 | 17646400 | |
| Pubmed | 2.60e-05 | 43 | 138 | 4 | 19077034 | ||
| Pubmed | 3.68e-05 | 405 | 138 | 9 | 38187761 | ||
| Pubmed | 3.71e-05 | 47 | 138 | 4 | 31235642 | ||
| Pubmed | 3.99e-05 | 17 | 138 | 3 | 22411552 | ||
| Pubmed | CCR4-dependent regulatory T cell function in inflammatory bowel disease. | 4.68e-05 | 3 | 138 | 2 | 17548518 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 28790178 | ||
| Pubmed | Abnormal chemokine receptor profile on circulating T lymphocytes from nonallergic asthma patients. | 4.68e-05 | 3 | 138 | 2 | 25178112 | |
| Pubmed | Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus. | 4.68e-05 | 3 | 138 | 2 | 20334681 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 30395542 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 21525208 | ||
| Pubmed | Differential PI(4,5)P2 sensitivities of TRPC4, C5 homomeric and TRPC1/4, C1/5 heteromeric channels. | 4.68e-05 | 3 | 138 | 2 | 30755645 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 20332182 | ||
| Pubmed | mgl-1, a mouse homologue of the Drosophila tumor-suppressor gene l(2)gl, maps to chromosome 11. | 4.68e-05 | 3 | 138 | 2 | 8020994 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 17404315 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 22269120 | ||
| Pubmed | Sustained hypoglycemia affects glucose transporter expression of human blood leukocytes. | 4.68e-05 | 3 | 138 | 2 | 12064911 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 2440899 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 27176146 | ||
| Pubmed | Piezo2 expressing nociceptors mediate mechanical sensitization in experimental osteoarthritis. | 4.68e-05 | 3 | 138 | 2 | 37120427 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 12401330 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 38999942 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 18299470 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 22663547 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 17611657 | ||
| Pubmed | Uterine inflammatory myofibroblastic tumor: First report of a ROS1 fusion. | 4.68e-05 | 3 | 138 | 2 | 34322931 | |
| Pubmed | Interferon-gamma suppresses Na+ -H+ exchanger in cultured human endolymphatic sac epithelial cells. | 4.68e-05 | 3 | 138 | 2 | 19479940 | |
| Pubmed | Rapid protection against viral infections by chemokine-accelerated post-exposure vaccination. | 4.68e-05 | 3 | 138 | 2 | 38348028 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 15138209 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 11991658 | ||
| Interaction | LMBRD2 interactions | 3.71e-06 | 65 | 129 | 6 | int:LMBRD2 | |
| Interaction | TTYH1 interactions | PIGN ABCA2 TMEM39B ERMP1 ANO10 LMBRD2 SLC35F5 SLC9A1 ANO6 GLRB ATP11C | 3.71e-06 | 300 | 129 | 11 | int:TTYH1 |
| Interaction | TSPAN15 interactions | 1.16e-05 | 276 | 129 | 10 | int:TSPAN15 | |
| Interaction | GPR21 interactions | 1.34e-05 | 81 | 129 | 6 | int:GPR21 | |
| Interaction | CCR6 interactions | 2.30e-05 | 89 | 129 | 6 | int:CCR6 | |
| Interaction | YIPF3 interactions | 2.67e-05 | 186 | 129 | 8 | int:YIPF3 | |
| Interaction | TBC1D8B interactions | 4.07e-05 | 11 | 129 | 3 | int:TBC1D8B | |
| Interaction | TBC1D9 interactions | 4.44e-05 | 61 | 129 | 5 | int:TBC1D9 | |
| Interaction | TNC interactions | 5.01e-05 | 32 | 129 | 4 | int:TNC | |
| Interaction | LRRC55 interactions | 6.50e-05 | 66 | 129 | 5 | int:LRRC55 | |
| Interaction | LANCL1 interactions | 8.41e-05 | 112 | 129 | 6 | int:LANCL1 | |
| Interaction | NIPAL1 interactions | 9.28e-05 | 114 | 129 | 6 | int:NIPAL1 | |
| Interaction | SYNGR2 interactions | 1.20e-04 | 75 | 129 | 5 | int:SYNGR2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p22 | 2.47e-04 | 184 | 138 | 5 | chr3p22 | |
| Cytoband | 9p24 | 2.48e-04 | 8 | 138 | 2 | 9p24 | |
| Cytoband | 16p13 | 6.85e-04 | 13 | 138 | 2 | 16p13 | |
| GeneFamily | Solute carriers | SLC2A9 SLC37A3 SLC22A15 SLC30A4 SLC2A3 SLC2A4 SLC35F5 SLC5A11 SLC6A2 SLC6A4 SLC9A1 SLC46A3 SLC9A3 SLC4A10 SLC9A7 SLC33A1 | 1.41e-09 | 395 | 107 | 16 | 752 |
| GeneFamily | ATPase phospholipid transporting | 1.51e-06 | 15 | 107 | 4 | 1210 | |
| GeneFamily | CD molecules|C-C motif chemokine receptors | 2.35e-05 | 10 | 107 | 3 | 1091 | |
| GeneFamily | Fibronectin type III domain containing | 4.63e-05 | 160 | 107 | 7 | 555 | |
| GeneFamily | WD repeat domain containing|GRAM domain containing|BEACH domain containing | 5.52e-05 | 13 | 107 | 3 | 1146 | |
| GeneFamily | WD repeat domain containing | 1.65e-04 | 262 | 107 | 8 | 362 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.22e-03 | 9 | 107 | 2 | 1203 | |
| GeneFamily | Anoctamins | 1.51e-03 | 10 | 107 | 2 | 865 | |
| GeneFamily | Blood group antigens|XK related family | 1.84e-03 | 11 | 107 | 2 | 955 | |
| GeneFamily | Potassium two pore domain channel subfamily K | 3.46e-03 | 15 | 107 | 2 | 277 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.44e-03 | 181 | 107 | 5 | 694 | |
| GeneFamily | Dyneins, axonemal | 4.45e-03 | 17 | 107 | 2 | 536 | |
| Coexpression | GSE11057_CD4_CENT_MEM_VS_PBMC_DN | 8.49e-06 | 195 | 136 | 8 | M3117 | |
| Coexpression | GSE17721_LPS_VS_CPG_16H_BMDC_DN | 1.02e-05 | 200 | 136 | 8 | M4009 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | RNF121 DDR1 DRAM1 OBSL1 ERMP1 ANO10 ORAI1 SLC9A1 ANO6 TMEM245 TMEM109 TRAM2 IL6ST WDR62 | 1.29e-05 | 681 | 136 | 14 | M5314 |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-08 | 170 | 138 | 8 | 749144a1a869a6bf9acdd227184319083367dc3f | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-08 | 170 | 138 | 8 | 25d60a62e8f99c31ab64fe6a0c07ccca3df1a7ee | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.21e-07 | 161 | 138 | 7 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.85e-07 | 166 | 138 | 7 | f62db9d9b6c9dd8f2afcaea0fc5f8c69f50205b2 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.98e-07 | 169 | 138 | 7 | 149a4f83da15bdeb170e980fb5b5b1af89ae07a6 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-06 | 171 | 138 | 7 | 6a0fafb8fd9fc7671618eeb2bf528ce8ce86b794 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-06 | 171 | 138 | 7 | e02b5831768dbb1b68998b672e55c9680ab0cc86 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-06 | 173 | 138 | 7 | 1b9b4e165121b08ef15a93fca6bea875cae69f19 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-06 | 173 | 138 | 7 | c25f24d7b672c9686d31ebc8d263042282f520fd | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-06 | 184 | 138 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-06 | 184 | 138 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-06 | 184 | 138 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.96e-06 | 187 | 138 | 7 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.42e-06 | 193 | 138 | 7 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | COVID-19-Myeloid-DC2|Myeloid / Condition, Lineage and Cell class | 2.42e-06 | 193 | 138 | 7 | 5f3f6db3d3de887d004662d229f42549601efa81 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.50e-06 | 194 | 138 | 7 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-06 | 197 | 138 | 7 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-06 | 200 | 138 | 7 | fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Serous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.06e-06 | 200 | 138 | 7 | 61bae10c8b12196d9cee766897971b81cb897191 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-maDC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.32e-06 | 153 | 138 | 6 | b03375c54aa701817c0fc2c3fef32b870169e697 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-MAIT|Leuk-UTI / Disease, Lineage and Cell Type | 8.32e-06 | 153 | 138 | 6 | ac3a1d1b5bf6009df818fd757dad7382d95c60dc | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.32e-06 | 153 | 138 | 6 | 18bd770a18e642581a6df144d47184c1ac383713 | |
| ToppCell | VE-CD8-CD4_Treg|VE / Condition, Cell_class and T cell subcluster | 1.11e-05 | 161 | 138 | 6 | a114f4f75859d9ef900e5146686438d051241429 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 168 | 138 | 6 | 4ae9e9d93bcd6f4d5815e57fd5afa7a3398a0ec1 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-mDC|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.42e-05 | 168 | 138 | 6 | 2dca1c4a33b6da9357fa3b2a523af19baab1c21c | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 169 | 138 | 6 | 454b92b9b67299a64278c010db033ca5b9d217a0 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.52e-05 | 170 | 138 | 6 | bf589c4297ccc90e5f51e3d0fcc229548af4fcef | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 172 | 138 | 6 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 172 | 138 | 6 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | P03-Epithelial-epithelial_progenitor_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.73e-05 | 174 | 138 | 6 | 23c7fdfc73170cfc5cdee5bb7fbee0c8bbbbca07 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 174 | 138 | 6 | 2afa5eea54b67c549c5058ece98296eee3829c11 | |
| ToppCell | P03-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.79e-05 | 175 | 138 | 6 | a6d9ca35d3c4b4e3889d0a69b514f63ae630da6b | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.82e-05 | 104 | 138 | 5 | b5ca6e589f414e549f4990fe334d4ee54829b298 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.84e-05 | 176 | 138 | 6 | ed7ba2a3af3b060dec98b60f09f96000a67f7e63 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.84e-05 | 176 | 138 | 6 | de746cdf2c777eec88cb03863e128e97ad6e8fb0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.90e-05 | 177 | 138 | 6 | 64fbf799e7b0c4003b2f486cc41b0f7e7c11ea0c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-05 | 177 | 138 | 6 | 2f81b26be89cc2fd8eafadaf7eae3c6ad6521462 | |
| ToppCell | droplet-Tongue-nan-24m-Myeloid-basal_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 178 | 138 | 6 | 9423e209de94d26e96117581c95dc069850225d3 | |
| ToppCell | COVID-19-kidney-REN+Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 2.03e-05 | 179 | 138 | 6 | 342c1cc4444f51b8dcb30d3adc98285a25669c6e | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 180 | 138 | 6 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 180 | 138 | 6 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 180 | 138 | 6 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.09e-05 | 180 | 138 | 6 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-05 | 181 | 138 | 6 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.16e-05 | 181 | 138 | 6 | 13270b6ba6a9c8e5681c6f40000c643ce1d9344a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_IL7R|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.16e-05 | 181 | 138 | 6 | 3e3c903b522dced6bec5dc447cc3f8bf9a9749e3 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-leukocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-05 | 183 | 138 | 6 | 062ec08d66c923f90fee771b1bf8d98bdc7e6c1b | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.37e-05 | 184 | 138 | 6 | 2c2125b8030af83f7a6d59a7102d4de8e0ac1988 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.37e-05 | 184 | 138 | 6 | 1c56378b3888c46258d446b47de4d6282fe74b0d | |
| ToppCell | T_cells-Resident_memory_CD8+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.37e-05 | 184 | 138 | 6 | e04cabff33a8e36967622ec3e5b37b89afa7e148 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.37e-05 | 184 | 138 | 6 | a45980306c4e697a2703bed72a7b48fb23d942f4 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.52e-05 | 186 | 138 | 6 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.59e-05 | 187 | 138 | 6 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-05 | 187 | 138 | 6 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 2.59e-05 | 187 | 138 | 6 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-05 | 187 | 138 | 6 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-05 | 188 | 138 | 6 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.75e-05 | 189 | 138 | 6 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-05 | 190 | 138 | 6 | c408d4033a130c0168159a5b6f286fd2b2a9a39d | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-DC2|Lung / Manually curated celltypes from each tissue | 2.84e-05 | 190 | 138 | 6 | 468525c05e38158a3b8a445882b2d63dfb1d2c63 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-05 | 190 | 138 | 6 | d4910c37045a8b8bb53b37625263bc0a47b6e3f8 | |
| ToppCell | COVID-19-Myeloid-DC2|COVID-19 / Condition, Lineage and Cell class | 2.92e-05 | 191 | 138 | 6 | 1304ab7b5713f29f3966ffc020ea1b52e8e2f375 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B-Memory_B_cells|GI_large-bowel / Manually curated celltypes from each tissue | 3.01e-05 | 192 | 138 | 6 | 31f7245bce79969674a775ecf175e7c6af68b503 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam_____kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-05 | 192 | 138 | 6 | 6fb56d062c35617b18b927704bf5fba894faed81 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam_____kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 193 | 138 | 6 | b397c14ac1e34c6be3f25d4417d200bc518d3048 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.10e-05 | 193 | 138 | 6 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 193 | 138 | 6 | 241a60d1f0d5832638fb3e1e4b7afa7387ea3c75 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 193 | 138 | 6 | fa8bcf2a5ab7b08fae98a1466a936995142b4309 | |
| ToppCell | IPF-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 3.19e-05 | 194 | 138 | 6 | 3892b188f424ffb80f3c75a1b6709a21c1e1601d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.19e-05 | 194 | 138 | 6 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.19e-05 | 194 | 138 | 6 | e56c6e5c9b7d287ae94566b561e21cec2055f83d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.28e-05 | 195 | 138 | 6 | c5d2d9f12fd893331c9de261af30607d845d4f6a | |
| ToppCell | NS-critical-LOC-Lymphoid-B_cell|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.28e-05 | 195 | 138 | 6 | 1c0d8dbe8490c35903061469e395b218416b1aa2 | |
| ToppCell | proximal-3-Hematologic-IGSF21+_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.28e-05 | 195 | 138 | 6 | 8592d0332bc82a91e173680cfd1afc5ee189b289 | |
| ToppCell | proximal-Hematologic-IGSF21+_Dendritic|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.28e-05 | 195 | 138 | 6 | c48ff83c48342875f06c6c9e7d5bc6084a992848 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.28e-05 | 195 | 138 | 6 | 85fee07d71c0393ea42bcf1130566dff4a62f507 | |
| ToppCell | Control-Myeloid-MoAM4|Control / Condition, Lineage and Cell class | 3.28e-05 | 195 | 138 | 6 | 211a736acbe875bd3c1942c62aaacc9b170ece6d | |
| ToppCell | proximal-Hematologic-IGSF21+_Dendritic-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.28e-05 | 195 | 138 | 6 | ae9d61011e95f7840cbb154738c79745fd29943e | |
| ToppCell | distal-Hematologic-Natural_Killer_T-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.38e-05 | 196 | 138 | 6 | 05d2a15ba702b07ef59c55891a06da02cdd15f7f | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.47e-05 | 197 | 138 | 6 | 156155c2f0c1a2461e45803da578af18ee221660 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.47e-05 | 197 | 138 | 6 | 032ccc91e604113da9bc34a6f9ddb1d45dea1892 | |
| ToppCell | Transverse-Dendritic_cell-Lymphoid_DC|Dendritic_cell / Region, Cell class and subclass | 3.47e-05 | 197 | 138 | 6 | 8545baf923ddf84c5ce9414a36d810603be52401 | |
| ToppCell | BAL-Mild-cDC_10|Mild / Compartment, Disease Groups and Clusters | 3.47e-05 | 197 | 138 | 6 | c0550d41dd5619b369b590f3d6a61154dd7b2cab | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.47e-05 | 197 | 138 | 6 | d5d9263451f6c10cb3b9c17740183ca334e24851 | |
| ToppCell | Transverse-(5)_Dendritic_cell-(53)_Lymphoid_DC|Transverse / shred on region, Cell_type, and subtype | 3.47e-05 | 197 | 138 | 6 | 15b87fd3906d7388c271d30d0c64b1bcc490801c | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Pericytes|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.47e-05 | 197 | 138 | 6 | 608328608cef82adc867a449216839622253d486 | |
| ToppCell | Transverse-Dendritic_cell-Lymphoid_DC|Transverse / Region, Cell class and subclass | 3.47e-05 | 197 | 138 | 6 | a58af0ea82f76f2a7abac1f62629ff20d552fc63 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.57e-05 | 198 | 138 | 6 | 59214e34b077dffa989c48635fdef143f57f1320 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.57e-05 | 198 | 138 | 6 | 7f7024b26337ae2bc7f57c3274a7dfdaaa64ab7c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.57e-05 | 198 | 138 | 6 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 3.67e-05 | 199 | 138 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.67e-05 | 199 | 138 | 6 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.67e-05 | 199 | 138 | 6 | b7af2b4fe6866cc8c78cf0f78390aab1b1b389ba | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-05 | 199 | 138 | 6 | 67d8c7e5356f5d409d4f98e8338cf6c499fd7aee | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.67e-05 | 199 | 138 | 6 | 2e7f517c0444b4f29ff11c26ab32e9cc0f7e99ef | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.78e-05 | 200 | 138 | 6 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-05 | 200 | 138 | 6 | ae91dc047dc80560ba298d8d21a772154fa2775d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 200 | 138 | 6 | 56f1f007ba8c9188a4b10e52744f1e50dc0f155a | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 200 | 138 | 6 | f0c338877e39226a90c4effe12f6501d33542a73 | |
| ToppCell | severe-immature_Neutrophil|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.78e-05 | 200 | 138 | 6 | a9b87accdaa6956116ab82427e1330e8f007ef94 | |
| Computational | Neighborhood of CDH4 | 3.24e-06 | 136 | 72 | 8 | MORF_CDH4 | |
| Computational | Neighborhood of MAP2K7 | 2.64e-05 | 181 | 72 | 8 | MORF_MAP2K7 | |
| Computational | Neighborhood of IL4 | 4.03e-05 | 192 | 72 | 8 | MORF_IL4 | |
| Computational | Neighborhood of FSHR | DRD1 GPR19 COLGALT2 SLC6A2 SLC46A3 KCNA5 CCR6 SLC33A1 HCRTR2 | 9.55e-05 | 279 | 72 | 9 | MORF_FSHR |
| Computational | Neighborhood of DMPK | 1.63e-04 | 175 | 72 | 7 | MORF_DMPK | |
| Computational | Neighborhood of MAGEA8 | 3.30e-04 | 260 | 72 | 8 | MORF_MAGEA8 | |
| Computational | Neighborhood of ATF2 | DRD1 GPR19 COLGALT2 SLC6A2 SLC6A4 SLC46A3 KCNA5 SLC33A1 HCRTR2 | 3.37e-04 | 330 | 72 | 9 | MORF_ATF2 |
| Computational | Neighborhood of IFNA1 | 4.27e-04 | 205 | 72 | 7 | MORF_IFNA1 | |
| Computational | Neighborhood of MDM2 | 5.29e-04 | 279 | 72 | 8 | MORF_MDM2 | |
| Computational | Neighborhood of PTPRR | 5.90e-04 | 102 | 72 | 5 | MORF_PTPRR | |
| Computational | Neighborhood of CAMK4 | 6.82e-04 | 290 | 72 | 8 | MORF_CAMK4 | |
| Computational | Neighborhood of MLLT10 | 8.89e-04 | 302 | 72 | 8 | MORF_MLLT10 | |
| Computational | B lymphoma expression clusters. | 9.02e-04 | 112 | 72 | 5 | MODULE_456 | |
| Computational | DRG (dorsal root ganglia) genes. | 1.00e-03 | 384 | 72 | 9 | MODULE_2 | |
| Computational | Genes in the cancer module 134. | 1.03e-03 | 30 | 72 | 3 | MODULE_134 | |
| Computational | Neighborhood of IL16 | 1.06e-03 | 239 | 72 | 7 | MORF_IL16 | |
| Computational | Neighborhood of PRKCA | 1.31e-03 | 181 | 72 | 6 | MORF_PRKCA | |
| Computational | Neighborhood of ERCC4 | 1.32e-03 | 321 | 72 | 8 | MORF_ERCC4 | |
| Computational | Neighborhood of SUPT3H | 1.51e-03 | 328 | 72 | 8 | MORF_SUPT3H | |
| Computational | Neighborhood of CTSB | 1.54e-03 | 187 | 72 | 6 | MORF_CTSB | |
| Computational | Genes in the cancer module 288. | 1.90e-03 | 37 | 72 | 3 | MODULE_288 | |
| Computational | Neighborhood of MAGEA9 | DRD1 GPR19 COLGALT2 SLC6A2 SLC6A4 SLC46A3 KCNA5 SLC33A1 HCRTR2 | 1.96e-03 | 423 | 72 | 9 | MORF_MAGEA9 |
| Computational | Genes in the cancer module 27. | 2.48e-03 | 355 | 72 | 8 | MODULE_27 | |
| Computational | Genes in the cancer module 99. | 2.57e-03 | 357 | 72 | 8 | MODULE_99 | |
| Computational | Complement and cAMP signaling. | 2.80e-03 | 12 | 72 | 2 | MODULE_575 | |
| Computational | Genes in the cancer module 11. | TNC COLGALT2 ATP9A SLC2A3 CHRNB1 TBC1D9 TRIM9 GLRB SYNGR1 MMD | 3.04e-03 | 540 | 72 | 10 | MODULE_11 |
| Computational | Neighborhood of NOS2A | 3.07e-03 | 288 | 72 | 7 | MORF_NOS2A | |
| Drug | Cocaine | 8.62e-08 | 8 | 137 | 4 | DB00907 | |
| Drug | Amoxapine | 1.17e-05 | 8 | 137 | 3 | DB00543 | |
| Drug | Octopamine | 1.17e-05 | 8 | 137 | 3 | ctd:D009655 | |
| Drug | Sodium | 1.18e-05 | 84 | 137 | 6 | ctd:D012964 | |
| Drug | NBDG | 1.74e-05 | 9 | 137 | 3 | CID000163790 | |
| Drug | 3-isoreserpine | 2.03e-05 | 190 | 137 | 8 | CID000005052 | |
| Drug | phentermine | 2.30e-05 | 28 | 137 | 4 | CID000004771 | |
| Drug | Oleandomycin phosphate [7060-74-4]; Up 200; 5uM; MCF7; HT_HG-U133A | 2.44e-05 | 195 | 137 | 8 | 5676_UP | |
| Drug | Paclitaxel [33069-62-4]; Up 200; 4.6uM; MCF7; HT_HG-U133A | 2.53e-05 | 196 | 137 | 8 | 5320_UP | |
| Drug | Karakoline [39089-30-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.72e-05 | 198 | 137 | 8 | 3638_UP | |
| Drug | Metronidazole [443-48-1]; Up 200; 23.4uM; PC3; HT_HG-U133A | 2.82e-05 | 199 | 137 | 8 | 4023_UP | |
| Drug | Niacin [59-67-6]; Down 200; 32.4uM; PC3; HT_HG-U133A | 2.82e-05 | 199 | 137 | 8 | 6702_DN | |
| Drug | 2-Chloropyrazine [14508-49-7]; Down 200; 35uM; PC3; HT_HG-U133A | 2.93e-05 | 200 | 137 | 8 | 5750_DN | |
| Drug | [11c]dasb | 3.39e-05 | 11 | 137 | 3 | CID000656408 | |
| Drug | Trimipramine | 3.39e-05 | 11 | 137 | 3 | DB00726 | |
| Drug | phenylpropanolamine | 3.48e-05 | 31 | 137 | 4 | CID000004786 | |
| Drug | potassium | CACNA1E DDR1 FN1 CHRNB1 EDNRA SLC2A4 SLC5A11 ORAI1 SLC9A1 SLC9A3 KCNA5 KCNK10 SCN10A SLC9A7 SV2C KCNK17 SLC33A1 STOM | 3.56e-05 | 1008 | 137 | 18 | CID000000813 |
| Drug | Protriptyline | 3.59e-05 | 2 | 137 | 2 | DB00344 | |
| Drug | Atomoxetine | 3.59e-05 | 2 | 137 | 2 | DB00289 | |
| Drug | Desvenlafaxine | 3.59e-05 | 2 | 137 | 2 | DB06700 | |
| Drug | Milnacipran | 3.59e-05 | 2 | 137 | 2 | DB04896 | |
| Drug | Amineptine | 3.59e-05 | 2 | 137 | 2 | DB04836 | |
| Drug | nisoxetine | 3.59e-05 | 2 | 137 | 2 | ctd:C011386 | |
| Drug | Ephedra | 4.51e-05 | 12 | 137 | 3 | DB01363 | |
| Drug | 5-mm AI | 4.51e-05 | 12 | 137 | 3 | CID000131575 | |
| Drug | talsupram | 4.51e-05 | 12 | 137 | 3 | CID000033013 | |
| Drug | quindine | 5.57e-05 | 219 | 137 | 8 | CID000001065 | |
| Drug | fenoldopam | 6.48e-05 | 70 | 137 | 5 | CID000003340 | |
| Drug | benzotropine mesylate | 7.10e-05 | 37 | 137 | 4 | CID000002344 | |
| Drug | CI-907 | 7.10e-05 | 37 | 137 | 4 | CID000005525 | |
| Drug | benzimidazol-2-one | 7.39e-05 | 14 | 137 | 3 | CID000162542 | |
| Drug | diphenyl sulfide | 7.39e-05 | 14 | 137 | 3 | CID000008766 | |
| Drug | 7-OH-DPAT | 8.76e-05 | 39 | 137 | 4 | CID000001219 | |
| Drug | D-161 compound | 1.07e-04 | 3 | 137 | 2 | ctd:C532102 | |
| Drug | Mazindol | 1.07e-04 | 3 | 137 | 2 | DB00579 | |
| Drug | Methylphenidate | 1.07e-04 | 3 | 137 | 2 | DB00422 | |
| Drug | Duloxetine | 1.07e-04 | 3 | 137 | 2 | DB00476 | |
| Drug | 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone | 1.07e-04 | 3 | 137 | 2 | ctd:C569113 | |
| Drug | Venlafaxine | 1.07e-04 | 3 | 137 | 2 | DB00285 | |
| Drug | 4-fluoroamphetamine | 1.07e-04 | 3 | 137 | 2 | ctd:C040639 | |
| Drug | Sibutramine | 1.07e-04 | 3 | 137 | 2 | DB01105 | |
| Drug | RTI-219 | 1.07e-04 | 3 | 137 | 2 | CID010524711 | |
| Drug | 2-(4-bromo-2,5-dimethoxyphenyl)ethylamine | 1.07e-04 | 3 | 137 | 2 | ctd:C079321 | |
| Drug | 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone | 1.07e-04 | 3 | 137 | 2 | ctd:C000592273 | |
| Drug | difluoropine | 1.07e-04 | 3 | 137 | 2 | CID000190851 | |
| Drug | Dexmethylphenidate | 1.07e-04 | 3 | 137 | 2 | DB06701 | |
| Drug | 2-(4-bromo-2,5-dimethoxyphenyl)-N-((2-methoxyphenyl)methyl)ethanamine | 1.07e-04 | 3 | 137 | 2 | ctd:C000595926 | |
| Drug | 1,4-diazabicyclo[3.3.1]nonane | 1.07e-04 | 3 | 137 | 2 | CID015140257 | |
| Drug | 5-N-(methyl-propyl)amiloride | 1.07e-04 | 3 | 137 | 2 | CID000193326 | |
| Drug | 5-(2-aminopropyl)benzofuran | 1.07e-04 | 3 | 137 | 2 | ctd:C000608250 | |
| Drug | 4-methoxymethamphetamine | 1.07e-04 | 3 | 137 | 2 | ctd:C060169 | |
| Drug | 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine | 1.07e-04 | 3 | 137 | 2 | ctd:C554181 | |
| Drug | nisoxetine | 1.18e-04 | 42 | 137 | 4 | CID000004500 | |
| Drug | MS-275; Up 200; 10uM; PC3; HT_HG-U133A | 1.28e-04 | 184 | 137 | 7 | 7074_UP | |
| Drug | bupropion | 1.30e-04 | 81 | 137 | 5 | CID000000444 | |
| Drug | MBDB | 1.36e-04 | 17 | 137 | 3 | CID000124844 | |
| Drug | mecoprop | 1.41e-04 | 44 | 137 | 4 | CID000007153 | |
| Drug | Protoveratrine A [143-57-7]; Down 200; 5uM; MCF7; HT_HG-U133A | 1.51e-04 | 189 | 137 | 7 | 2800_DN | |
| Drug | Clomipramine hydrochloride [17321-77-6]; Up 200; 11.4uM; PC3; HT_HG-U133A | 1.61e-04 | 191 | 137 | 7 | 4487_UP | |
| Drug | OPC-18790 | 1.63e-04 | 18 | 137 | 3 | CID000060790 | |
| Drug | ICI 182,780; Up 200; 0.01uM; MCF7; HT_HG-U133A | 1.71e-04 | 193 | 137 | 7 | 6997_UP | |
| Drug | Vitamin K2 [11032-49-8]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.71e-04 | 193 | 137 | 7 | 3880_UP | |
| Drug | alpha-Santonin [481-06-1]; Up 200; 16.2uM; PC3; HT_HG-U133A | 1.77e-04 | 194 | 137 | 7 | 4531_UP | |
| Drug | Clofazimine [2030-63-9]; Down 200; 8.4uM; PC3; HT_HG-U133A | 1.77e-04 | 194 | 137 | 7 | 4682_DN | |
| Drug | radicicol; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.77e-04 | 194 | 137 | 7 | 5952_DN | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 1.83e-04 | 195 | 137 | 7 | 2643_UP | |
| Drug | Clofazimine [2030-63-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.83e-04 | 195 | 137 | 7 | 5277_DN | |
| Drug | AC1L197G | 1.83e-04 | 47 | 137 | 4 | CID000000426 | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 1.89e-04 | 196 | 137 | 7 | 4749_DN | |
| Drug | pentamidine isethionate salt; Up 200; 100uM; MCF7; HG-U133A | 1.89e-04 | 196 | 137 | 7 | 639_UP | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; HL60; HG-U133A | 1.89e-04 | 196 | 137 | 7 | 1558_DN | |
| Drug | Acyclovir [59277-89-3]; Up 200; 17.8uM; PC3; HT_HG-U133A | 1.89e-04 | 196 | 137 | 7 | 4683_UP | |
| Drug | Sulfapyridine [144-83-2]; Up 200; 16uM; MCF7; HT_HG-U133A | 1.89e-04 | 196 | 137 | 7 | 6101_UP | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 1.89e-04 | 196 | 137 | 7 | 1497_UP | |
| Drug | Theobromine [83-67-0]; Up 200; 22.2uM; MCF7; HT_HG-U133A | 1.89e-04 | 196 | 137 | 7 | 4958_UP | |
| Drug | Thioperamide maleate [106243-16-7]; Down 200; 9.8uM; PC3; HT_HG-U133A | 1.89e-04 | 196 | 137 | 7 | 4675_DN | |
| Drug | verapamil | CACNA1E ABCA2 CHRNB1 EDNRA TBC1D9 ORAI1 SLC9A1 KCNA5 KCNK10 SCN10A KCNK17 | 1.90e-04 | 490 | 137 | 11 | CID000002520 |
| Drug | 5-DMA | 1.92e-04 | 19 | 137 | 3 | CID000001793 | |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 1uM; MCF7; HT_HG-U133A | 1.95e-04 | 197 | 137 | 7 | 4758_UP | |
| Drug | Pivampicillin [33817-20-8]; Up 200; 8.6uM; PC3; HT_HG-U133A | 1.95e-04 | 197 | 137 | 7 | 5046_UP | |
| Drug | rotenone; Down 200; 1uM; PC3; HT_HG-U133A | 1.95e-04 | 197 | 137 | 7 | 5948_DN | |
| Drug | Lactobionic acid [96-82-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 1.95e-04 | 197 | 137 | 7 | 6605_UP | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; HL60; HT_HG-U133A | 1.95e-04 | 197 | 137 | 7 | 3063_UP | |
| Drug | valdecoxib; Down 200; 10uM; PC3; HT_HG-U133A | 1.95e-04 | 197 | 137 | 7 | 6408_DN | |
| Drug | Benzonatate [104-31-4]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.95e-04 | 197 | 137 | 7 | 5435_UP | |
| Drug | Demecarium bromide [56-94-0]; Up 200; 5.6uM; HL60; HG-U133A | 1.95e-04 | 197 | 137 | 7 | 1781_UP | |
| Drug | Calcium | CACNA1E DDR1 DRD1 TRPC4 TRPC5 EDNRA JAK2 ORAI1 SLC9A1 CCR4 IL6ST | 2.00e-04 | 493 | 137 | 11 | ctd:D002118 |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Up 200; 25.2uM; PC3; HT_HG-U133A | 2.01e-04 | 198 | 137 | 7 | 3755_UP | |
| Drug | Phthalylsulfathiazole [85-73-4]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.01e-04 | 198 | 137 | 7 | 5614_UP | |
| Drug | Megestrol acetate [595-33-5]; Down 200; 10.4uM; HL60; HT_HG-U133A | 2.01e-04 | 198 | 137 | 7 | 3091_DN | |
| Drug | Finasteride [98319-26-7]; Up 200; 10.8uM; HL60; HT_HG-U133A | 2.01e-04 | 198 | 137 | 7 | 2206_UP | |
| Drug | Adrenosterone [382-45-6]; Up 200; 13.4uM; HL60; HT_HG-U133A | 2.01e-04 | 198 | 137 | 7 | 3107_UP | |
| Drug | Antipyrine [60-80-0]; Up 200; 21.2uM; PC3; HT_HG-U133A | 2.01e-04 | 198 | 137 | 7 | 4251_UP | |
| Drug | Fosfosal [6064-83-1]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 2.01e-04 | 198 | 137 | 7 | 3336_UP | |
| Drug | Nicardipine hydrochloride [54527-84-3]; Up 200; 7.8uM; PC3; HT_HG-U133A | 2.01e-04 | 198 | 137 | 7 | 6297_UP | |
| Drug | Betahistine mesylate [54856-23-4]; Up 200; 17.2uM; HL60; HT_HG-U133A | 2.01e-04 | 198 | 137 | 7 | 2472_UP | |
| Drug | Pregnenolone [145-13-1]; Up 200; 12.6uM; PC3; HT_HG-U133A | 2.01e-04 | 198 | 137 | 7 | 4218_UP | |
| Drug | Dacarbazine [4342-03-4]; Down 200; 22uM; MCF7; HT_HG-U133A | 2.01e-04 | 198 | 137 | 7 | 6816_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.07e-04 | 199 | 137 | 7 | 4348_UP | |
| Drug | Gelsemine [509-15-9]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 2.07e-04 | 199 | 137 | 7 | 4177_UP | |
| Disease | nephrotic syndrome type 20 (implicated_via_orthology) | 3.41e-07 | 4 | 131 | 3 | DOID:0070357 (implicated_via_orthology) | |
| Disease | Recurrent depression | 7.04e-06 | 9 | 131 | 3 | C0221480 | |
| Disease | pleural tuberculosis (is_marker_for) | 1.00e-05 | 10 | 131 | 3 | DOID:106 (is_marker_for) | |
| Disease | Primary Erythermalgia | 5.85e-05 | 3 | 131 | 2 | C0014805 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 5.85e-05 | 3 | 131 | 2 | C1833661 | |
| Disease | pulmonary hypertension (implicated_via_orthology) | 9.88e-05 | 54 | 131 | 4 | DOID:6432 (implicated_via_orthology) | |
| Disease | venous thromboembolism, response to surgery | 1.17e-04 | 4 | 131 | 2 | EFO_0004286, EFO_0009951 | |
| Disease | leishmaniasis (is_marker_for) | 1.17e-04 | 4 | 131 | 2 | DOID:9065 (is_marker_for) | |
| Disease | nephrolithiasis (implicated_via_orthology) | 1.94e-04 | 5 | 131 | 2 | DOID:585 (implicated_via_orthology) | |
| Disease | Depressive Disorder, Treatment-Resistant | 1.94e-04 | 5 | 131 | 2 | C2063866 | |
| Disease | hypertension (is_implicated_in) | 2.10e-04 | 121 | 131 | 5 | DOID:10763 (is_implicated_in) | |
| Disease | pulmonary hypertension (is_implicated_in) | 3.18e-04 | 30 | 131 | 3 | DOID:6432 (is_implicated_in) | |
| Disease | heart conduction disease (implicated_via_orthology) | 3.86e-04 | 32 | 131 | 3 | DOID:10273 (implicated_via_orthology) | |
| Disease | Congenital Pain Insensitivity | 4.05e-04 | 7 | 131 | 2 | C0002768 | |
| Disease | hyperuricemia (implicated_via_orthology) | 4.05e-04 | 7 | 131 | 2 | DOID:1920 (implicated_via_orthology) | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 4.05e-04 | 7 | 131 | 2 | C0020075 | |
| Disease | excessive daytime sleepiness measurement | 4.23e-04 | 33 | 131 | 3 | EFO_0007875 | |
| Disease | alcoholic liver cirrhosis (is_marker_for) | 6.90e-04 | 9 | 131 | 2 | DOID:14018 (is_marker_for) | |
| Disease | epilepsy (implicated_via_orthology) | 8.22e-04 | 163 | 131 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 8.60e-04 | 10 | 131 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 8.60e-04 | 10 | 131 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | membranoproliferative glomerulonephritis (biomarker_via_orthology) | 8.60e-04 | 10 | 131 | 2 | DOID:2920 (biomarker_via_orthology) | |
| Disease | obstructive sleep apnea (is_implicated_in) | 1.05e-03 | 11 | 131 | 2 | DOID:0050848 (is_implicated_in) | |
| Disease | response to angiotensin-converting enzyme inhibitor, Cough | 1.13e-03 | 46 | 131 | 3 | EFO_0005325, HP_0012735 | |
| Disease | nicotine dependence (implicated_via_orthology) | 1.25e-03 | 12 | 131 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.25e-03 | 12 | 131 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Streptozotocin Diabetes | 1.39e-03 | 108 | 131 | 4 | C0038433 | |
| Disease | Diabetes Mellitus, Experimental | 1.39e-03 | 108 | 131 | 4 | C0011853 | |
| Disease | Alloxan Diabetes | 1.39e-03 | 108 | 131 | 4 | C0002152 | |
| Disease | squamous cell carcinoma, multiple keratinocyte carcinoma susceptibility measurement, basal cell carcinoma | 1.48e-03 | 13 | 131 | 2 | EFO_0000707, EFO_0004193, EFO_0007932 | |
| Disease | Congestive heart failure | 1.49e-03 | 110 | 131 | 4 | C0018802 | |
| Disease | Heart failure | 1.49e-03 | 110 | 131 | 4 | C0018801 | |
| Disease | Left-Sided Heart Failure | 1.49e-03 | 110 | 131 | 4 | C0023212 | |
| Disease | Heart Failure, Right-Sided | 1.49e-03 | 110 | 131 | 4 | C0235527 | |
| Disease | Heart Decompensation | 1.49e-03 | 110 | 131 | 4 | C1961112 | |
| Disease | Myocardial Failure | 1.49e-03 | 110 | 131 | 4 | C1959583 | |
| Disease | Alzheimer disease | 1.49e-03 | 485 | 131 | 8 | MONDO_0004975 | |
| Disease | Hypertensive disease | 1.62e-03 | 190 | 131 | 5 | C0020538 | |
| Disease | triacylglycerol 52:1 measurement | 1.72e-03 | 14 | 131 | 2 | EFO_0010413 | |
| Disease | Drug habituation | 1.75e-03 | 115 | 131 | 4 | C0013170 | |
| Disease | Drug abuse | 1.75e-03 | 115 | 131 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.75e-03 | 115 | 131 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 1.75e-03 | 115 | 131 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 1.75e-03 | 115 | 131 | 4 | C0013222 | |
| Disease | Drug Dependence | 1.75e-03 | 115 | 131 | 4 | C1510472 | |
| Disease | Substance Dependence | 1.75e-03 | 115 | 131 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 1.75e-03 | 115 | 131 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.75e-03 | 115 | 131 | 4 | C0029231 | |
| Disease | Substance abuse problem | 1.81e-03 | 116 | 131 | 4 | C0740858 | |
| Disease | hematocrit | ACACA DNAH2 EDNRA LLGL1 OR10AD1 ASB3 NR5A2 PKHD1 SLC9A7 AFF1 TMEM163 HCRTR2 | 1.86e-03 | 1011 | 131 | 12 | EFO_0004348 |
| Disease | Cocaine-Related Disorders | 1.87e-03 | 117 | 131 | 4 | C0236736 | |
| Disease | Schizophrenia | DDR1 PAG1 DRD1 NPSR1 SLC6A2 SLC6A4 WDR11 TMEM245 SYNGR1 CCR5 CSMD1 | 1.98e-03 | 883 | 131 | 11 | C0036341 |
| Disease | rheumatoid arthritis (is_implicated_in) | 2.21e-03 | 58 | 131 | 3 | DOID:7148 (is_implicated_in) | |
| Disease | blood osmolality measurement | 2.21e-03 | 58 | 131 | 3 | EFO_0007967 | |
| Disease | Cocaine Abuse | 2.52e-03 | 127 | 131 | 4 | C0009171 | |
| Disease | Vitiligo | 2.55e-03 | 17 | 131 | 2 | C0042900 | |
| Disease | major depressive disorder (is_implicated_in) | 2.55e-03 | 17 | 131 | 2 | DOID:1470 (is_implicated_in) | |
| Disease | apolipoprotein B measurement | 2.89e-03 | 663 | 131 | 9 | EFO_0004615 | |
| Disease | pulmonary hypertension (is_marker_for) | 2.92e-03 | 64 | 131 | 3 | DOID:6432 (is_marker_for) | |
| Disease | portal hypertension (implicated_via_orthology) | 3.18e-03 | 19 | 131 | 2 | DOID:10762 (implicated_via_orthology) | |
| Disease | inflammatory bowel disease (is_implicated_in) | 3.18e-03 | 19 | 131 | 2 | DOID:0050589 (is_implicated_in) | |
| Disease | ankylosing spondylitis (is_implicated_in) | 3.18e-03 | 19 | 131 | 2 | DOID:7147 (is_implicated_in) | |
| Disease | renovascular hypertension (biomarker_via_orthology) | 3.18e-03 | 19 | 131 | 2 | DOID:1591 (biomarker_via_orthology) | |
| Disease | Cocaine Dependence | 3.48e-03 | 139 | 131 | 4 | C0600427 | |
| Disease | hypertension (biomarker_via_orthology) | 3.50e-03 | 227 | 131 | 5 | DOID:10763 (biomarker_via_orthology) | |
| Disease | triacylglycerol 46:1 measurement | 3.53e-03 | 20 | 131 | 2 | EFO_0010401 | |
| Disease | IgA glomerulonephritis (is_marker_for) | 3.53e-03 | 20 | 131 | 2 | DOID:2986 (is_marker_for) | |
| Disease | Malignant Glioma | 3.77e-03 | 70 | 131 | 3 | C0555198 | |
| Disease | mixed gliomas | 3.77e-03 | 70 | 131 | 3 | C0259783 | |
| Disease | hyperglycemia (biomarker_via_orthology) | 3.89e-03 | 21 | 131 | 2 | DOID:4195 (biomarker_via_orthology) | |
| Disease | Colorectal Carcinoma | 4.19e-03 | 702 | 131 | 9 | C0009402 | |
| Disease | depressive disorder (implicated_via_orthology) | 4.26e-03 | 22 | 131 | 2 | DOID:1596 (implicated_via_orthology) | |
| Disease | triacylglycerol 48:2 measurement | 4.26e-03 | 22 | 131 | 2 | EFO_0010405 | |
| Disease | triacylglycerol 48:3 measurement | 4.26e-03 | 22 | 131 | 2 | EFO_0010406 | |
| Disease | glomerular filtration rate, renal transplant outcome measurement, donor genotype effect measurement | 4.26e-03 | 22 | 131 | 2 | EFO_0005199, EFO_0005208, EFO_0007892 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IDFIVTVVFSFLWLV | 116 | Q8TBG9 | |
| LFFWGTVFLITTTLV | 261 | O00400 | |
| VTHTLSSEFTILWSV | 146 | Q8NAP1 | |
| RIFTTASDVWSFGIV | 801 | P21709 | |
| TVVAITVLISTATFW | 711 | Q96JP9 | |
| SILTLWFTTDFAVSA | 116 | Q96PZ7 | |
| DNIIWALLTLFTVST | 1356 | Q15878 | |
| TWNIFDFITVIGSIT | 1541 | Q15878 | |
| WLLFSEISFISDVVN | 356 | Q08345 | |
| VFTAITWISFSSSAS | 311 | Q15760 | |
| ETWSSLCTFFLSIVQ | 216 | Q14512 | |
| VWGLSVIISSSTFVF | 171 | P51684 | |
| VVDRLFLWTFIIFTS | 466 | P11230 | |
| FLWTFIIFTSVGTLV | 471 | P11230 | |
| VISDILDWKTSRTFF | 2201 | Q13085 | |
| VTAIEIVSIWILSFI | 201 | P25101 | |
| ITSLATWSVAVFASL | 156 | P51679 | |
| VSVQIALDTSYWTFI | 1006 | Q8TF62 | |
| FILISVAWTLSVLIS | 141 | P21728 | |
| TAVVLVWVVSAAVSF | 156 | P13945 | |
| VVTSVITWVVAVFAS | 146 | P51681 | |
| IVFFSSDWALLTLVT | 216 | A2RUS2 | |
| WLVSFAEESAFSTVL | 611 | Q9Y485 | |
| WFTSLVTVLIIAVFI | 461 | Q7Z2K6 | |
| FITSAETVNIWSLTD | 1496 | Q9ULI1 | |
| TWVYESTVFLSSTIF | 191 | Q8NH16 | |
| TWVYEGTVFLSTTIF | 191 | Q8NG85 | |
| LTESKFSVASDVWSF | 1026 | O60674 | |
| AAIWVASVVFSTLFI | 166 | Q01726 | |
| IQISWIDDTSAFVSL | 471 | O95453 | |
| VTAVTLHTEWSLVAF | 601 | Q15334 | |
| FASFNLIWSTVILEL | 246 | Q9NW15 | |
| ASAVFFWILLIIASV | 456 | Q4KMQ2 | |
| VTWSSAAFIISYVVA | 16 | Q8N682 | |
| AYFTVTITDVSSWIV | 886 | O75147 | |
| SLWAIFADAIVVILS | 196 | Q8NGE0 | |
| TVLAVASWVFSFLLA | 141 | Q96R47 | |
| LAATVATFAITTLWL | 366 | Q9HCP6 | |
| VFTIVGNSVVLFSTW | 61 | Q6W5P4 | |
| TLTTLWALSVAIFSV | 76 | P14672 | |
| FLDVAFITTVTFLWK | 1101 | O43861 | |
| FITTVTFLWKVSAIT | 1106 | O43861 | |
| WAFSTVIGTLLFLAE | 176 | Q96D31 | |
| WELVGSFFFSVSTIT | 101 | Q96T54 | |
| VIWTSAAFIFSYITA | 16 | Q6UX65 | |
| TVLTWSSLTLESFFQ | 681 | Q96JB1 | |
| FTERDTFIETFILWV | 111 | Q5H8C1 | |
| TTAFLILISLWVEEA | 6 | P48167 | |
| WTALESIYFVVVTLT | 261 | P57789 | |
| FIATLSFLWKVSVIT | 1006 | O75110 | |
| ALFIVSTVFHIVSWK | 71 | Q15546 | |
| SESFIFDNVTISLTW | 261 | Q7Z442 | |
| WTIVSEFVLVSFSAL | 6 | Q9H209 | |
| LWVFVHIPSSSTFII | 66 | Q9BPV8 | |
| TLVVDITETWFFGQS | 111 | O43614 | |
| NSWIDSVSIDTLIFT | 411 | Q9Y575 | |
| WATFQLEITFTAITD | 491 | Q93033 | |
| TWLVQALFIFLTTES | 6 | P40189 | |
| IVETTCVIWFTFELL | 326 | P22460 | |
| FAVFQWSFSALLITT | 16 | Q6E213 | |
| WSFSALLITTTVIAV | 21 | Q6E213 | |
| ESVTEITASSFVVSW | 726 | P02751 | |
| FVVSWVSASDTVSGF | 736 | P02751 | |
| AWFITGFVQLSISVT | 751 | Q9BZC7 | |
| NVVWSKFETIFFTIS | 201 | Q9NZK5 | |
| EVLLTSLWSLSVAIF | 56 | P11169 | |
| LTLLWSVTVSIFAIG | 106 | Q9NRM0 | |
| VLEFSSIHTSIWITV | 106 | Q6DWJ6 | |
| TWTFDDIIVFAFSSR | 261 | Q8IYK4 | |
| FETWLDNISVTFLSL | 6 | Q9UKT8 | |
| NVSVDSLSWEFIVST | 4301 | Q9P225 | |
| SSSFTSIASEWFLIA | 91 | Q8IZD6 | |
| QTLFSIVEWARSSIF | 351 | O00482 | |
| VFLTHWVFGEVSLVS | 206 | Q9H720 | |
| AIFSLSFFISVWTSE | 241 | Q9NYV8 | |
| IKVLEWIASIFAFAT | 36 | Q16563 | |
| VTLVATFLWLVSTSA | 156 | Q16563 | |
| VTVSFTFFWLVAAAA | 156 | Q5VXT5 | |
| STLSGSTFWAVVFFV | 396 | P23975 | |
| TAFWIVFSIIHIIAT | 631 | Q8NBJ9 | |
| DNTIKLTIVWFTLSF | 431 | Q496J9 | |
| VIWVASSELTSYVFT | 81 | Q8WV83 | |
| FSVIVVWSECTFFST | 396 | Q68DH5 | |
| WNTAFVLLTLVFISV | 366 | P48764 | |
| FEWSFLIIAVSLAVN | 196 | Q7Z3Q1 | |
| ITLHWFLTAFASVVD | 276 | Q96HU1 | |
| QSTWDTVAFIVFLTF | 26 | K7EJ46 | |
| FLFVLAVGLWSTVKT | 36 | Q8WWX8 | |
| VTGTTLFQSFTVWES | 2386 | P08F94 | |
| TFFTSTWEVIRSAAV | 1511 | Q7Z745 | |
| TLWGSLAAVAIFFVI | 16 | Q9NWQ8 | |
| SLSTSEVDFAFLVWQ | 501 | Q92935 | |
| GWILVAFSFLFTVIT | 31 | P27105 | |
| LSFTIFNYESIVWTT | 181 | Q8TER0 | |
| GVISSISLSWFLTLF | 661 | Q66K14 | |
| VTITSHVLTAFDLWE | 1146 | P51825 | |
| QFSVFALTTIGWILS | 11 | H7C241 | |
| AWVFSFLVLEVTSVL | 6 | O75339 | |
| WTFGTIVFTVLVFTV | 996 | Q8NB49 | |
| VLVSQASLWFATFLS | 86 | Q9NYW4 | |
| VFWRLFTISSRVISF | 361 | Q5GH73 | |
| IFLWDVNTLTALTAS | 141 | Q8TAF3 | |
| SSALVVFVFGALTEW | 121 | Q8NCC5 | |
| VSVHSWFSLFITVTI | 126 | Q9Y5Y9 | |
| ESGQLVVFHFTSVIW | 116 | Q15035 | |
| ASVSLSWFLTLFLSI | 661 | O95759 | |
| LFWSVILFFSTVTLS | 726 | Q6U841 | |
| STISLSWFLTLFLSV | 671 | Q6ZT07 | |
| FVERVTAVWKSIFSL | 1156 | Q8TEQ6 | |
| VIFSDITENSATVSW | 1716 | P24821 | |
| YSVHSFLTIWTTVVA | 286 | Q9GZP7 | |
| FTWVLFLATVDSFTT | 1651 | Q9H5I5 | |
| FLATVDSFTTWLNSI | 1656 | Q9H5I5 | |
| WSSVSETLIFIFLGV | 386 | P19634 | |
| TILRVVSWLFSIVVF | 26 | O43759 | |
| VSWLFSIVVFGSIVN | 31 | O43759 | |
| VIWILFSAVTAFVTF | 106 | Q9H920 | |
| SLVFDITVITIDWIS | 1221 | P08922 | |
| TLLRVASWVFSIAVF | 26 | O43761 | |
| AFSFFSILSWVALTV | 151 | O43761 | |
| TSLSWTFFSLLLAVF | 591 | O95427 | |
| WAISSAISVAFFALS | 86 | Q9BVC6 | |
| SVLEAVVCFFSVWSI | 251 | Q8IZN3 | |
| KTLVLQTSEVAWFAF | 526 | Q9C026 | |
| VRFWFLEVSTETKVT | 221 | O43379 | |
| LTAWSRTLVTFKDVF | 6 | P21506 | |
| FTTILSFFSGISLLW | 101 | Q6GV28 | |
| TSDIYFVSLVWAIVV | 351 | Q9H330 | |
| FIVTVHWVSLETASF | 496 | P86452 | |
| VFSLLVAFTTFRIIW | 311 | O14863 | |
| VAFTTFRIIWDTVVI | 316 | O14863 | |
| QLTISWTVLVLFFTV | 86 | Q5TGU0 | |
| SWFESFIIFVILLSS | 1056 | Q9UI33 | |
| NVRITLFWTVLFTLT | 196 | Q9H0C3 | |
| LFWTVLFTLTSVVVL | 201 | Q9H0C3 | |
| STLFETLQSLFWSVF | 566 | Q9UL62 | |
| QVSLTFEDVAVLFTW | 11 | Q96LW1 | |
| IEWTSLTSFLSFATS | 521 | Q9BZH6 | |
| TTTLLIVFFTVWIIG | 511 | Q96T83 | |
| VLTVALIEAVAVSWF | 501 | P31645 | |
| VFVSTSWVIYVVVAL | 246 | A0A1B0GWB2 | |
| VSWFSIIVTLALAVA | 91 | Q8TC26 | |
| WFLVVFVDSVVSDIL | 831 | Q9UPU7 | |
| FSTLFETLQSLFWSI | 561 | Q9UBN4 | |
| HIITFLSEITLIWFS | 351 | Q8IWR1 | |
| LSEITLIWFSEASLS | 356 | Q8IWR1 | |
| FLTRFTVLTATGWSL | 161 | Q9GZU3 | |
| FLLSDSILLVATWVT | 291 | Q9H6D3 | |
| LYSTEITLWTVVAAI | 36 | Q6ZMS7 | |
| FSFTAILTALEFWSR | 2501 | Q9P2D8 | |
| LVFFVETISVILWVS | 841 | Q14CX7 |